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In eukaryotes, the ubiquitin-proteasome system (UPS) degrades most cellular protein. 
Inhibition of the UPS has been associated with different disease states and can affect various 
intracellular processes including the activation of heat shock protein (hsp) gene expression. 
During cellular stress, HSPs act as molecular chaperones by inhibiting protein aggregation 
and assisting in their refolding once normal conditions are re-established. In the present 
study, Withaferin A (WA), a steroidal lactone with possible anti-inflammatory and antitumor 
properties, was found to inhibit proteasome activity and induce the expression of hsp genes 
in the amphibian model system, Xenopus laevis.  Treatment of Xenopus kidney epithelial A6 
cells with WA produced an increase in the accumulation of ubiquitinated protein and a 
significant decrease in chymotrypsin-like activity. Furthermore, immunoblot analysis 
revealed that WA induced HSP30 and HSP70 accumulation. For example, cells treated with 
5 µM WA for 18 h resulted in the optimal accumulation of HSP30 and HSP70. Northern blot 
analysis revealed that exposure of cells to 5 µM WA induced hsp30 and hsp70 mRNA 
accumulation in a time-dependent manner up to 12 h. The activation of heat shock factor 1 
(HSF1) DNA-binding may be involved in WA-induced hsp gene expression in A6 cells, 
since pretreatment with the HSF1 inhibitor, KNK437, reduced the accumulation of HSP30 
and HSP70. Also, WA acted synergistically with mild heat shock to enhance HSP 
accumulation to a greater extent than the sum of both stressors individually. In cells 
recovering from WA, the relative levels of HSP30 and HSP70 accumulation remained 
elevated from 6 to 12 h after removal of WA. Immuocytochemical analysis and laser 
scanning confocal microscopy revealed that WA-induced HSP30 accumulation occurred 
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primarily in the cytoplasm with some staining in the nucleus in a granular or punctate pattern. 
Prolonged exposure to WA resulted in some disorganization of the actin cytoskeleton as well 
as large cytoplasmic HSP30 staining structures in some cells. Prior exposure of cells to WA 
treatment conferred thermotolerance since it protected them against a subsequent thermal 
challenge at 37 °C. In conclusion, this study has shown that WA can induce an inhibition of 
proteasome activity and an increase hsp gene expression. Activating the heat shock response 
is a potential avenue for novel drug therapies, which can confer cytoprotection in disease 
states involving cytotoxic protein aggregation.  
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Protein homeostasis, encompassing RNA metabolism and processing, protein 
synthesis, folding, translocation, assembly and disassembly is regulated by a complex 
network of components in the cell (Morimoto, 2008). These processes, accomplished in the 
crowded cellular environment, are influenced by physical, metabolic and environmental 
pressures, such as oxidation by reactive oxygen species (ROS), temperature and changes in 
small molecule metabolite concentrations (Powers, et al., 2009). Deregulation of proteastasis 
can result in loss of function, gain of toxic function and aggregation of proteins. Chaperones, 
such as heat shock proteins (HSPs), help circumvent this problem by holding protein in a 
folding competent state, preventing aggregation of unfolded polypeptides and refolding 
unfolded protein to their native conformation or promoting protein degradation when 
necessary (Powers, et al., 2009). Increased HSP accumulation protects against stress-induced 
damage with a direct correlation between the level of stress and the amount of HSP 
synthesized (Gupta et al., 2010). 
1.1 Heat Shock Proteins 
Heat shock proteins were first observed by Ritossa (1962) in the salivary glands of 
Drosophila melanogaster larvae, in response to elevated temperature. HSPs were initially 
named because of their induction by heat shock. However, they are expressed in response to 
many factors including cell growth and development, environmental influences, 
pathophysiological stress and protein conformation diseases (Morimoto, 2008; Gupta et al., 
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2010). Synthesis of inducible HSPs, via the heat shock response (HSR), occurs as a result of 
cellular stress such as exposure to heat, alcohol, hypoxia, heavy metals, hydrogen peroxide 
and the accumulation of abnormal proteins (Shamovsky and Nudler, 2008). Constitutively 
expressed HSPs were later found in addition to the stress inducible forms. Under normal 
conditions, the constitutively expressed HSPs perform maintenance duties including folding 
of nascent chains, regulation of protein quality control, and assisting in apoptotic regulation 
by interacting with members of the death cascade (Morimoto, 2008; Kalmar and Greensmith, 
2009). A defining characteristic of HSPs is their ability to prevent misfolding, and potential 
aggregation with other unfolding intermediates, as well as to hold proteins in a folding 
competent state so as to allow their refolding (Morimoto, 2008). As molecular chaperones, 
HSPs work to capture non-native intermediates and nascent chains by recognizing exposed 
hydrophobic stretches, normally hidden inside the native conformation (Morimoto and 
Santoro, 1998). 
HSPs have been found in all organisms, from bacteria to mammals, and are classified 
into groups according to their size (Shamovsky and Nudler, 2008). In vertebrates, the six 
families identified thus far are HSP100 (including HSP110), HSP90 HSP70, HSP60, HSP40 
and the small heat shock proteins (sHSPs) that range from 10 – 42 kDa. This introduction 
will focus on the HSP70 family and the sHSPs.   
1.1.1 HSP70 
The 70 kDa heat shock protein (HSP70) is involved in a wide array of folding 
processes including, folding of newly synthesized proteins, transport of proteins across 
membranes and refolding of misfolded proteins (Morimoto, 2008). HSP70 promotes folding 
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of nascent chains on ribosomes under normal conditions, and holds unfolded intermediates in 
a folding competent state to prevent aggregation by interacting with hydrophobic surfaces 
exposed during cell stress (Katschinski, 2004). Folding of proteins into their native 
conformation is restricted to HSP70, while its ability to hold proteins in a folding competent 
state is common among many HSPs (Morimoto, 2008). Biological activity of regulatory 
proteins is controlled through transient interactions of HSP70 with nuclear receptors, kinases 
and transcription factors (Mayer and Bukau, 2005). HSP70 also promotes degradation of 
proteins, by the proteasome or lysosome, when they are no longer needed (Kalmar and 
Greensmith, 2009). Interaction of HSP70 with members of the caspase-independent and 
caspase-dependent apoptosis pathways is necessary for inhibition of apoptosis and cell 
survival (Beere et al., 2000; Mayer and Bukau, 2005). HSP70 regulates this broad and 
complex network of cellular functions through diversification in hsp70 evolution, which 
generated specialized HSP70 chaperones, substrate specificity via co-chaperones and 
cooperation with other chaperone systems (Mayer and Bukau, 2005).  
As a collective, the HSP70 molecular chaperones are the most abundant family of 
HSPs as they are found in every organism in multiple cellular compartments. Members of the 
HSP70 family include the stress inducible HSP70 and constitutive heat shock cognate 
(HSC70), both relegated to the cytoplasm, as well as a mitochondrial HSP70 (mitHSP70) and 
immunoglobulin binding protein (BiP) also known as glucoses-regulated protein 78 
(GRP78), which is located in the endoplasmic reticulum (Meimaridou et al., 2009). The 
HSP70s are a highly conserved family of proteins, having 74% identity between the amino 
acid sequence of Drosophila and Xenopus HSP70 while the heat shock cognate, HSC70, has 
92% identity between Xenopus, mouse, rat and bovine (Heikkila et al., 1997).  
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The multi-domain organization of HSP70 includes a 45 kDa amino-terminal ATPase 
domain, an 18 kDa peptide binding domain near the carboxyl end and a G/C rich domain 
containing a 7 kDa EEVD regulatory motif at the extreme C-terminal (Freeman et al., 1995; 
Morimoto and Santoro 1998; Daugaard et al., 2007; Shamovsky and Nudler, 2008). In 
addition, HSP70 relies on an ATPase cycle, which consists of alternation between an ADP 
bound state with high substrate affinity and an ATP bound state with low substrate affinity 
(Mayer and Bukau, 2005). ATP binding induces conformational changes in the substrate-
binding domain opening a pocket and helical lid for binding of HSP70 client proteins (Bukau 
et al., 2006).  
HSP70 binds a wide variety of proteins to accomplish its diverse cellular processes. 
Co-chaperones like the DNAJ family, Hip, Hop and Bag influence these interactions by 
conferring client protein specificity (Mayer and Bukau, 2005; Morimoto, 2008; Kalmar and 
Greensmith, 2009). Protein misfolding is detected by HSP70, which then forms complexes 
with HSP90 and co-chaperones. The J domain family of proteins (DNAJ) mediate ATP 
hydrolysis dependent locking of substrates in the binding cavity of HSP70. Chaperone 
activity is dependent on the J domain of these co-chaperones interacting with the ATPase 
domain of HSP70. Association of the HSP70 complex with HSP70-HSP90 organizing 
protein (HOP) or HSP-interacting protein (HIP) increase ATPase activity and thus refolding. 
If the HSP70-HSP90 complex interacts with other co-chaperones such as CHIP or BAG this 
will result in decreased HSP70-ATPase activity. The BAG family of proteins, particularly 
BAG-1, may antagonize the function of HIP by competing for the ATPase domain of HSP70. 
Co-chaperone assisted repression of HSP70 folding activity results in ubiquitination of the 
client protein and subsequent degradation. 
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1.1.2 Small HSPs 
The small HSP superfamily is a ubiquitous group of proteins within the cell and is 
involved in numerous cellular processes such as actin capping and decapping, cellular 
differentiation, prevention of apoptosis and acquisition of thermotolerance (MacRae, 2000; 
Mounier and Arrigo, 2002; Heikkila, 2004). sHSPs also interact with unfolding proteins, 
holding them in a folding competent state. SHSPs are the most diverse family of stress 
proteins in structure and function, yet they are found in nearly every cellular compartment in 
almost every organism (Franck et al., 2004; Nakamoto and Vigh, 2007). Many organisms 
express multiple members of the sHSP family often with several members in one cellular 
compartment (Franck et al., 2004). 
SHSPs have a varied domain structure (Kim et al., 1998; Franck et al., 2004; Sun and 
MacRae, 2005a; Nakamoto and Vigh, 2007). The only conserved region, named for the 
protein in which it was first discovered, is a C-terminal α-crystallin domain, comprised of 80-
100 amino acids. This region is folded into a β-sandwich conformation, which consists of 
two anti-parallel β-sheets and intersubunit binding of these sheets facilitates dimer formation, 
the building blocks for oligomeric complexes. Flanking the α-crystallin domain are a non-
conserved amino terminal domain and a flexible carboxyl terminal extension, required for 
stability and chaperone activity. The varied size of sHSPs, from 10-42 kDa, is primarily due 
to the variable length of the N-terminal region and presence or absence of the C-terminal 
extension. 
Almost all sHSPs assemble into large oligomeric complexes of 9 to over 30 subunits 
and up to 2 MDa in size (Haley et al., 1998; Kim et al., 1998; Nakamoto and Vigh, 2007). 
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The oligomeric crystal structure was defined in several organisms as a hollow globular 
sphere and consisted of multiple different sHSPs in one complex. SHSP quaternary structure 
was found to be dynamic and variable with subunits that freely and rapidly exchanged 
between oligomers (Haley et al., 1998; van Montfort et al., 2002; Stromer et al., 2003).  
Formation of oligomers and their reversible dissociation into smaller subunits was required 
for in vitro chaperone activity (van Montfort et al., 2001; Stromer et al, 2003; Nakamoto and 
Vigh, 2007) and involved temperature-regulated exposure of their hydrophobic surfaces, 
making them available for substrate binding. Substrate-bound sHSPs may rejoin formed 
multimers as several substrate proteins were found bound to each assembly, up to one client 
per sHSP dimer (van den Oetelaar et al., 1990; Bova et al., 1997; Stromer et al., 2003; 
Haslbeck et al., 2005). SHSP complexes suppress the aggregation of denaturing proteins by 
holding them in a folding competent state such that the client proteins can be folded by other 
chaperones, such as HSP70 and HSP90, upon stress attenuation (Arrigo, 1998; Nakamoto 
and Vigh, 2007). Phosphorylation of sHSPs resulted in the formation of smaller multimeric 
units and severely inhibited chaperone activity (Lavoie et al., 1995; Fernando et al., 2003; 
Shashidharamurthy et al., 2005). The phosphorylation-induced changes attenuated sHSP-
substrate binding and may enable ATP-dependent HSPs access to client proteins for 
refolding. Client protein specificity has not been detected thus far which may account for the 
wide variety of sHSP-associated processes (Stromer et al., 2003). 
Numerous sHSPs have been identified in almost every organism, the most widely 
studied being HSP27, αA-crystallin and αB-crystallin. These three sHSPs were found in all 
vertebrates studied to date (Miron et al., 1991; Sawada et al., 1992; Lu et al., 1995; Behrens 
et al., 1998; Kawazoe et al., 1999; Posner et al., 1999; Norris and Hightower, 2002; 
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Panasenko et al., 2002; Franck et al., 2004; Heikkila, 2010). The α-crystallins are major 
constituents of the human eye lens and as such prevent proteins from forming light scattering 
aggregates. αA-crystallin is confined to the lenticular compartment, however αB-crystallin is 
involved in cytoprotective and regulatory processes in many other tissues (Franck et al., 
2004; Haslbeck et al., 2005). HSP27, also known as HSP25 in mice or HSPB1, has protein 
holding chaperone capabilities and its expression is elevated during heat shock (Brown et al., 
2007). 
1.1.2.1 HSP30 
An additional group of sHSPs, parologous to those in humans, is the HSP30 family. 
First discovered in amphibian systems, it was thought to be the counterpart to HSP25/27. 
However, it is now known that HSP30 is a distinct family of HSPs with homologs found in 
avian, amphibian and fish classes (Krone et al., 1992; Tam and Heikkila, 1995; Helbing et 
al., 1996; Norris et al., 1997; Norris and Hightower, 2002; Katoh et al., 2004; Kondo et al., 
2004; Wang et al., 2007). HSP30 has properties very similar to those of HSP27 and other 
sHSPs including chaperone activity, stress inducibility, phosphorylation-induced structural 
alterations and muscle localization.  
1.2 Heat Shock Factor 1 and the Heat Shock Response 
Heat shock factor 1 (HSF1) is responsible for stress-induced hsp gene expression in 
eukaryotes (Shamovsky and Nudler, 2008). Rapid HSF1 activation, upon exposure to cellular 
stress, involves trimerization of pre-existing HSF1 monomers, translocation to the nucleus 
and subsequent DNA binding (Fig. 1) (Morimoto, 2008). HSFs are poorly conserved among 
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different species, apart from the organization of their protein domains (Shamovsky and 
Nudler, 2008). The most highly conserved domain, an N-terminal helix-turn-helix DNA 
binding region, is the point of interaction between HSF1 and the heat shock element (HSE) 
which is located in the upstream promoter region of hsp genes (Akerfelt et al., 2007; 
Morimoto, 2008). DNA binding requires at least two copies of HSF1, however the active 
trimer has much greater affinity for the HSE than either the HSF1 monomer or dimer 
(Rabindran et al., 1993; Shamovsky and Nudler, 2008). Trimerization occurs via three 
separate leucine zipper domains: hydrophobic repeat-A (HR-A) and HR-B near the N-
terminus, and HR-C located closer to the C-terminus. The N-terminal repeats of adjacent 
transcription factors are required for trimer formation, while the HR-C maintains HSF1 in its 
monomeric state. Under non-stressed conditions, intramolecular coiled-coil interactions, 
between the N-terminal and C-terminal leucine zippers, presumably masks the hydrophobic 
domains from interacting with other HSF1 monomers. Heat shock, as well as other cellular 









Figure 1. Model of the heat shock response. During cellular stress, HSP has greater affinity 
for unfolded protein than for HSF1 monomers. HSF is then phosphorylated and trimerizes 
into an active state whereupon it translocates to the nucleus to bind HSE. Transcription and 














consequently HSF1 trimer repression. A C-terminal activation domain and a regulatory 
domain located within the central region are also necessary for HSF1 activity (Shamovsky 
and Nudler, 2008; Pirkkala et al., 2001). Control of the activation domain is through the 
regulatory region, which contains sites for constitutive and inducible serine 
pohosphorylation. For example, phosphorylation at serine 303, 307 and 363 are key for the 
negative regulation of HSF1 activity at normal temperatures, while phosphorylation at serine 
230 is enhanced upon heat shock, and has a positive effect on the transcription factor’s 
activity. Sumoylation, the addition of ubiquitin-like peptides to specific lysine residues in the 
regulatory domain, may also modulate DNA binding and transcriptional activity of HSF1 
(Hong et al., 2001). 
HSF1 is the primary regulator of the stress-induced increase in hsp gene expression 
that protects against proteotoxic stress (Akerfelt et al., 2007). hsp gene expression is also 
regulated at the levels of mRNA stability, translation, activity and the subcellular localization 
of chaperones (Katschinski, 2004). In addition, post-translational modifications, such as 
phosphorylation, can alter the structure and function of some HSPs (Fernando et al., 2003; 
Papp et al., 2003; Nakamoto and Vigh, 2007). The fine balance of proteostasis maintained in 
the cell, demands a fast and efficient response to proteotoxic stress. Once there is an excess 
of HSPs available to process the unfolded protein, HSF1 re-associates with HSPs in its 
inactive monomeric form (Morimoto, 1998). Hsp genes are only transcribed when HSF1 is 
bound to the HSE therefore cessation of the HSR occurs almost immediately after stress 
alleviates.  
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The mechanism of HSF1 activation is still largely unknown, however, formation of 
multichaperone complexes including HSP90, HSP70/HSP40, HIP, HOP and p23 were shown 
to inhibit HSF1 activation (Shamovsky and Nudler, 2008). An increase in protein 
intermediates appears during stress, shifting chaperone equilibrium away from HSF 
monomers alleviating its repression (Morimoto, 2008). Unfolded protein has been proposed 
as the shared mechanism behind the various stressors that induce the HSR and HSF1 
activation. However, HSF1 activity may also be regulated by the tandem action of the 
translational elongation factor, eEF1α, and constitutively expressed heat shock RNA-1 
(HSR1) (Shamovsky et al., 2006). Both eEF1α and HSR1 were required for HSF1 activation 
in in vitro and in vivo studies employing antisense oligonucleotides or short interfering RNA 
against HSR1 which depleted HSR1. eEF1α is a key component regulating the actin 
cytoskeleton and mRNA translation; HSR-induced protein synthesis inhibition and increased 
cytoskeletal collapse, may free eEF1α for interaction with HSF1 (Gross and Kinzy, 2005). 
Direct recognition of cell stress by HSR1, without unfolded protein, was also seen in vitro 
with purified HSF1 whose transcriptional activity increased in response to oxidative stress 
and low pH. Gross and Kinsey (2005) postulated that HSR1 may act as a the thermosensor of 
the cell, directly recognizing cell stress. In addition, HSF1 DNA binding activity was 
inhibited by a nuclear localized hydrophobic repeat containing protein, HSF binding protein 
(Morimoto, 1998). This indicates that the passive removal of HSPs may not act alone to 
activate HSF1 upon cell stress. 
HSF1 is the master regulator of heat-inducible hsp gene expression in vertebrates, but 
other HSFs have been identified as well. HSF2, which is found in all vertebrates, is regulated 
by developmental conditions (Pirkkala et al., 2001) and although not activated in response to 
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classical stress, was shown to act cooperatively with HSF1 during stress (Ostling et al., 
2007). In avian species an additional transcription factor, HSF3, was stress responsive and 
directly affected the activity and trimerization of HSF1 (Pirkkala et al., 2001). HSF3 was 
activated in response to severe heat shock and, unlike HSF1, the transcription of this factor 
was also induced with elevated temperature (Pirkkala et al., 2001). In mammals, HSF4, an as 
yet uncharacterized transcription factor, was preferentially expressed in the human heart, 
brain, skeletal muscle and pancreas. Lacking both the C-terminal hydrophobic repeat and 
transcriptional activation capability, it was suggested that HSF4 functions as a repressor of 
hsp gene expression (Nakai et al., 1997). In support of this, HSF4 specifically interacted with 
αB-crystallin promoter in post-natal development, possibly out-competing HSF1 and HSF2 
for DNA binding (Somasundaram and Bhat, 2004). 
1.3 Heat shock proteins and disease 
Protein homeostasis is a dynamic relationship between relative protein levels and 
their function within the cell. Chaperone and co-chaperone levels, for example, can alter 
networks of proteins therefore enhancing or dampening some signaling pathways, with long-
term imbalances likely having dramatic consequences on diverse cellular processes (Quinlan 
and van den Ijssel, 1999; Heikkila, 2003; Sun and MacRae, 2005b). SHSP synthesis and 
mutation have been linked to a number of diseases, including cataracts, ischemia during heart 
attack and stroke, Parkinson’s, Alzheimer’s and neuromuscular disorders. For example, a 
missense mutation in the gene that codes for αB-crystallin has been found to cause desmin-
related myopathy with the formation of protein inclusions comprising the intermediate 
filaments of the desmin class (Quinlan and van den Ijssel, 1999). In addition, a frameshift 
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mutation in the same crystallin gene produced an aberrant protein and was shown to be 
associated with congenital cataracts (Vicart et al., 1998; Perng et al., Perng et al., 1999; Berry 
et al., 2001). HSPs have also been implicated in many cardiovascular diseases (Snoeckx et 
al., 2001; Gupta et al., 2004). Elevated levels of HSPs were found in patients with systemic 
hypertension, coronary artery disease, carotid atherosclerosis, and myocardial infarction and 
ischemia. There are many human diseases that have been linked to chaperone and 
proteasome dysfunction that are pathologically defined by the abnormal deposition of 
misfolded polypeptides. Among these are severe neuropathologies like prion diseases, 
Alzheimer’s and Huntington’s, in which misfolded proteins aggregate in fibrillar structures, 
known as amyloids (Taylor et al., 2002; Muchowski and Wacker, 2005).  In addition, the 
neurodegenerative Parkinson’s disease may involve abnormal accumulation of the protein α-
synuclein bound to ubiquitin in the damaged cells. The α-synuclein-ubiquitin complex cannot 
be directed and degraded by the proteasome and forms cytotoxic Lewy bodies, proteinaceous 
cytoplasmic inclusions (Masliah et al., 2000; Muchowski and Wacker, 2005). Finding ways 
to alleviate proteotoxicity by enhancing molecular chaperones has shown promise as a 
potential therapeutic (Morimoto, 2008). 
1.4 Xenopus laevis 
Xenopus laevis is an excellent model organism useful for studying development, and 
its cell and molecular biology have also been extensively examined. It possesses 
physiological traits common to most other vertebrates and the cellular and molecular data 
collected using amphibian systems are, to a great extent applicable to mammals (Burggren 
and Warburton, 2007). As one of many species of the genus Xenopus, X. laevis is a South 
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African clawed frog native to Southern and Western Africa. This animal is entirely aquatic, 
preferring stagnat pools of water and spends little if any time on land (Deuchar, 1975). In 
such a habitat, Xenopus would encounter dynamic environmental changes and is therefore an 
interesting organism for stress response research. Xenopus laevis is also a desirable organism 
for experimental embryology and developmental analyses as the female frogs can be 
hormonally stimulated to lay eggs, the oocytes are fertilized in vitro and the embryos grow 
rapidly, reaching tadpole stage in a matter of days (Sive et al., 2000; Brown, 2004; Heikkila 
et al., 2007). The large egg size, approximately 1.1 mm in diameter, allows visual 
observation of developmental progression and facilitates microinjection as well as provides a 
large amount of protein and nucleic acids for molecular analysis. 
Additionally, Xenopus continuous cell lines are useful tools for in vitro molecular 
analyses. The Xenopus laevis A6 epithelial cell line, which was used in this study, was 
initially established by Rafferty (1969) from normal kidney cells of the renal uriniferous 
tubule of the adult male frog. The A6 cell line is easy and inexpensive to maintain and has a 
rapid doubling time of approximately 24 h making it an excellent tool for cellular and 
molecular biology research. A6 cells have been utilized as an experimental system in many 
areas of research including, proliferation and differentiation, genetic profiling under zero 
gravity, the function of Cystic Fibrosis transmembrane conductance regulator channels, and 
the role of renal epithelial sodium channels in hypertension (Guerra, 2004; Bjerregaard, 
2007; Ikuzawa et al., 2007; Wang et al., 2008). A6 cells have also been used to characterize 
the expression of numerous Xenopus hsp genes including hsp110, hsp90, hsp70, BiP, hsp47 
and hsp30 (Darasch et al., 1988; Tam and Heikkila, 1995; Ali et al., 1996a; Ali et al., 1996b; 
Briant et al., 1997; Miskovic et al., 1997; Gauley and Heikkila, 2006; Hamilton and Heikkila, 
 16 
2006). A6 cells have also been utilized to study hsp gene expression in response to various 
stressors including heat shock, sodium arsenite, herbimycin A, hydrogen peroxide, cadmium 
chloride, MG132 and celastrol (Darasch et al., 1988; Briant et al., 1997; Muller et al., 2004; 
Gauley and Heikkila, 2006; Woolfson and Heikkila, 2009; Young et al., 2009; Walcott and 
Heikkila, 2010; Young and Heikkila, 2010). A6 cells have also been used to study functional 
characteristics of HSPs. For example, experiments in A6 cells determined that HSP30 
assembles into high molecular weight aggregates in order to function as a molecular 
chaperone (Ohan et al., 1998).  
1.4.1 hsp30 and hsp70 genes in Xenopus laevis 
1.4.1.1 hsp30 
The hsp30 gene family is part of the shsp gene superfamily and 2 gene clusters 
(hsp30A/B and hsp30C/D/E) have been isolated so far in Xenopus laevis (Heikkila et al., 
1997; Heikkila, 2010). While the first to be identified were hsp30A and hsp30B (Bienz, 
1984), it was later discovered that hsp30A had an insertional mutation in its coding region 
and resulted in a truncated protein, while hsp30B was a pseudogene. Subsequently, hsp30C 
and hsp30D were isolated and encoded functional 24 kDa proteins (Krone et al., 1992; 
Heikkila, 2003). The hsp30E gene, for which a partial gene fragment is available, has yet to 
be characterized (Krone et al., 1992; Heikkila et al., 1997). Analysis of hsp30C revealed the 
presence of multiple cis-acting elements: 2 TATA boxes, 3 HSEs and 1 CCAAT box at the 
same relative location. Furthermore, the hsp30C gene lacked introns but the AT rich 3’ end 
contained a polyadenylation sequence and mRNA instability sequence (Heikkila, 2010). 
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1.4.1.2 hsp70 
Members of the hsp70 gene family were first isolated in Xenopus by Bienz (1984). 
Coding regions of the stress inducible hsp70 gene and 2 constitutive heat shock cognate 
genes hsc70.I and hsc70.II, all of which are cytoplasmic, have been isolated or characterized 
in our laboratory (Bienz, 1984; Ali et al., 1996a; Ali et al., 1996b). To date, four-70 kDa 
genes have been isolated in Xenopus, hsp70A-D, although only the full gene of hsp70A was 
analyzed. As well as being intronless, the 5’ region contained cis-acting elements including a 
TATA and CCAAT box and 3 HSEs (Heikkila, 2010).  
1.4.2 Expression and function of HSP30 in Xenopus laevis A6 cells 
Multiple HSP30 isoforms were detected using 2-D SDS PAGE and immunoblot 
analysis which suggested a relatively large hsp30 gene family (Tam and Heikkila, 1995). 
Further analysis of the HSP30C and HSP30D protein structure revealed the presence of an α-
crystallin domain, conserved in all eukaryotic sHSPs, (Krone et al., 1992) and a highly polar 
carboxyl-terminal end required for solubility of itself its client proteins (Fernando and 
Heikkila, 2000; Fernando et al., 2002). Additionally, HSP30C and HSP30D were capable of 
molecular chaperone activity, in vitro and in vivo, by inhibiting heat-induced client protein 
aggregation and maintaining heat or chemically denatured luciferase in a folding competent 
state (Fernando and Heikkila, 2000; Abdulle et al., 2002; Fernando et al., 2002). 
SHSPs are some of the most strongly induced HSPs (Arrigo and Landry, 1994; 
Haslbeck, 2002). In A6 cells, hsp30 gene expression was induced by heat shock, MG132, 
sodium arsenite, herbimycin A, hydrogen peroxide, celastrol, and cadmium treatment (Briant 
et al., 1997; Fernando et al., 2003; Muller et al., 2004; Woolfson and Heikkila, 2009; Walcott 
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and Heikkila, 2010; Young and Heikkila, 2010). Combined treatments with multiple stressors 
were found to act synergistically on the accumulation of HSP30 in A6 cells (Heikkila et al., 
1987; Young et al., 2009). For example, cells treated with concurrent mild heat shock and 
sodium arsenite exhibited an elevated level of HSP30 accumulation that was greater than the 
sum of each stress individually (Young et al., 2009). 
Although hsp gene expression is primarily regulated at the transcriptional level by 
HSF1, post-translational modifications may affect the structure and function of HSP30. 
Phosphorylation of serine residues, by mitogen-activated protein kinase activated protein 
kinase-2 (MAPKAPK-2), resulted in alterations of HSP30’s secondary structure and the 
formation of smaller complexes, rather than the large, oligomeric structures required for its 
chaperone activity (Fernando et al., 2003). Fernando et al., (2003) proposed that during 
cellular recovery from stress in Xenopus, the role of phosphorylation was to accelerate the 
release of tightly bound HSP30 particles from its targets by inducing a change in the 
oligomeric assembly of HSP30. Thus, chaperones such as HSP70 are able to access the target 
proteins in order to assist in their refolding and reactivation. 
1.4.3 Localization of HSP30 in A6 cells 
Previous studies, using immunocytochemistry and laser scaning confocal microscopy 
(LSCM), reported that heat shock-induced HSP30 accumulation was observed primarily in 
the cytoplasmic region, in a punctate pattern, likely corresponding to high molecular weight 
complexes of sHSP associated with unfolded protein (Gellalchew and Heikkila, 2005). 
Similar findings with respect to HSP30 localization were observed in cadmium, MG132, 
sodium arsenite or celastrol-treated A6 cells (Voyer and Heikkila, 2008; Woolfson and 
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Heikkila, 2009; Walcott and Heikkila; 2010; Young and Heikkila, 2010). Previous studies 
have also shown co-localization of Xenopus HSP30 with F-actin cytoskeletal disorganization 
at higher heat shock temperatures, which suggests that HSP30 may be involved in protecting 
cytoskeletal proteins and other cytoplasmic proteins (Gellalchew and Heikkila, 2005; 
Manwell and Heikkila, 2007). Acquisition of stress-tolerance, determined by monitoring 
cellular morphology and appearance of cytoskeletal actin filaments, was conferred in A6 
cells by heat shock or combinations of MG132, arsenite and heat shock. This was mediated 
by HSPs, such as HSP30, since HSF1 inhibition repressed tolerance (Young et al., 2009; 
Young and Heikkila, 2010). Additionally, in A6 cells treated with higher concentrations of 
sodium arsenite, accumulation of HSP30 was observed in the cytoplasm as well as a small 
amount in the nucleus, but not in the nucleolus (Gellalchew and Heikkila, 2005).  
1.4.4 Expression and function of HSP70 in Xenopus laevis A6 cells 
Several members of the Xenopus HSP70 family have been investigated including the 
stress-inducible HSP70, constitutively expressed HSC70 and BiP (Ali et al., 1997; Briant et 
al., 1997; Miskovic and Heikkila, 1999; Ali and Heikkila, 2002). HSC70 and HSP70 are 
cytosolic with functional nuclear localization signals while BiP is confined to the 
endoplasmic reticulum (Goldfarb et al., 2006; Heikkila et al., 2007). HSP70 and HSC70 are 
both involved in appropriate folding and trafficking of newly synthesized proteins in the cell, 
however, recent studies on surface proteins in oocytes suggest these HSPs have differential 
and antagonistic effects (Goldfarb et al., 2006). Previously in our laboratory, it was shown 
that hsp70 gene expression was induced by a variety of stressors including heat shock, 
sodium arsenite, celastrol and cadmium (Heikkila et al., 1997; Young et al., 2009; Woolfson 
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and Heikkila, 2009; Walcott and Heikkila, 2010). In A6 cells, hsp70 mRNA was not detected 
constitutively at 22 ºC however, heat shock-induced hsp70 accumulation was detected at 30 
ºC with peak levels at 35-37 ºC (Gauley and Heikkila, 2006). The stress-induced 
accumulation of hsp70 mRNA and protein were also observed in A6 cells treated with 
various stressors such as herbimycin A, hydrogen peroxide, ethanol, celastrol and cadmium 
(Darasch et al., 1988; Briant et al., 1997; Muller et al., 2004; Gauley and Heikkila, 2006; 
Woolfson and Heikkila, 2009; Walcott and Heikkila, 2010). 
1.5 Ubiquitin proteasome system 
 Protein homeostasis is dependent on the cooperation between protein synthesis, 
folding and degradation. Misfolded, aged or damaged proteins are targeted for degradation 
by the ubiquitin proteasome system (UPS). Ubiquitin molecules are reversibly added in long 
chains to target proteins by a cascade of ubiquitin activating, ubiquitin conjugating and 
ubiquitin ligating enzymes (Tanaka, 2009). Ubiquitin ligases provide the specificity to the 
ubiquitin pathway since they recognize and bind to specific substrate sequences. 
Downstream, ubiquitinated proteins are processed and degraded by the proteasome. The 26S 
proteasome complex is comprised of a 20S core particle and 2 capping 19S regulatory 
particles. The 19S cap particles are responsible for recognition and processing of 
ubiquitinated proteins before degradation by the 20S particle. The 20S core is a hollow 
cylinder of heptameric stacked rings with individual subunits of either α or β in an αββα 
conformation (Yang et al., 2007). The α subunits control substrate translocation into the 
catalytic core whereas the β subunits contain the catalytic sites with chymotrypsin-like (β5), 
trypsin-like (β2) and peptidyl glutamyl peptide hydrolyzing (β1) activity (Tanaka, 2009).The 
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ubiquitinated substrate is then hydrolysed via an ATP-dependent mechanism and ubiquitin 
molecules are removed and recycled by deubiquitination enzymes present on the 19S 
particle. Figure 2 shows a simplified schematic of the UPS. As the primary proteolytic 
complex in the cell, the proteasome is tightly linked to cellular protein homeostasis. Control 
of protein degradation and turnover require the cooperative action of recognition by 
molecular chaperones, and recycling of peptides for the synthesis of new proteins. Inhibition 
of proteasomal activity results in a build up of polyubiquitinated protein which can act as a 
trigger for hsp gene expression.  
1.6 Withaferin A 
For centuries, traditional Indian medicine has utilized plants and their derivatives to 
treat ailments of the endocrine, cardiopulmonary, and central nervous systems (Mishra et al., 








Figure 2. A model of the UPS. Polypeptides are marked for proteasomal degradation by the 
addition of chains of ubiquitin molecules by ubiquitinating enzymes (E1, E2 and E3). 
Ubiquitin moieties are recognized by the 19S particle and the protein is subsequently 
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degraded within the 26S proteasome. Small peptide chains and free ubiquitin molecules are 
released for recycling by the cell. MG132 inhibits proteasomal activity (Adapted from Lee 
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(Withania somnifera) has been gaining more attention lately with its acceptance as a dietary 
supplement in North America (Yang et al., 2007). Of the 40 compounds extracted from the 
leaves and roots of Ashwaganda, withaferin A (WA), a steroidal lactone (Fig. 3), is thought 
to be the active component responsible for its therapeutic properties (Mandal et al., 2008). 
Additional research has shown that WA inhibited angiogenesis by prevention of nuclear 
factor-κB (NFκB) activation, and had anti-carcinogenic, anti-tumor and radiosensitizing 
activity (Devi et al., 1995; Mohan et al., 2004; Malik et al., 2007; Yang et al., 2007; Mandal 
et al., 2008). For example WA was capable of inducing apoptosis in leukemic cells with no 
toxicity to normal human progenitor cells (Mandal, 2008). Furthermore, in Swiss albino 
mice, WA inhibited tumor growth and increased tumor free survival in a dose-dependent 
manner (Devi et al., 1995). Malik et al. (2007) determined that WA-induced apoptosis was 
mitochondrial-mediated and initiated by the generation of reactive oxygen species. Oxidative 
metabolites produce post-translational modifications often resulting in abhorrent or damaged 
proteins that may not fold properly. Unfolded protein is known to be an activator of the HSR 
and hsp gene expression.  
Recently, WA was shown to potently inhibit the chymotrypsin-like activity of a 
purified rabbit 20S proteasome and 26S proteasome in human prostate cancer cells. 
Inhibition of prostate tumor cellular proteasome activity in culture and tissue by WA resulted 
in accumulation of ubiquitinated protein that was accompanied by apoptosis (Yang et al., 
2007). It was also suggested that the conjugated ketone carbons at positions 1 and 24 of WA 
facilitated WA-induced proteasome inhibition by directly interacting with the catalytically 










Figure 3. Schematic of withaferin A molecular structure. Carbons 1 and 24 are marked 








 laboratory, MG132 and lactacystin, both potent proteasomal inhibitors, were shown to 
induce expression of hsp30 and hsp70 in Xenopus laevis A6 cells (Young and Heikkila, 
2010). Proteasome inhibition has great potential for use in cancer treatment and prevention 
(An et al., 1998; Orlowski, 1999; Drexler et al., 2000; Li et al., 2000; Soligo et al., 2001). 
Additionally, a recent study by Yu et al. (2010) on inhibition of HSP90 activity also 
determined that HSP70 accumulation increased in response to WA. Since the majority of 
studies performed to date have been on tumor cell lines, it would be interesting to study WA-
treated non-cancerous epithelial cells. In hamsters, for example, WA elicited a protective 
effect on normal RBCs, yet, induced apoptosis in cancerous cells (Manoharan et al., 2009). 
In order to realize the therapeutic potential of this plant extract, its effect on proteostasis 




Xenopus laevis is an excellent vertebrate model system from which developmental 
and molecular results are readily transferable. However, the experimental parameters need to 
be determined in a continuous cell line prior to utilization of Xenopus embryos. The primary 
goal of this thesis was to determine the effect of WA on proteasome activity and hsp gene 
expression in Xenopus laevis A6 kidney epithelial cells. The objectives for this study are as 
follows: 
• To analyze the accumulation of cellular protein conjugated to ubiquitin in cells treated 
with WA 
• To examine chymotrypsin-like activity of the 26S proteasome in WA-treated cells 
• To investigate the effect of WA on the expression of hsp30 and hsp70 genes expression 
• To determine whether HSF1 activation was involved in WA-induced accumulation of 
HSP30 and HSP70  
• To examine the pattern of HSP30 and HSP70 accumulation in cells simultaneously 
exposed to both WA and a mild heat shock  
• To analyze the WA-induced localization of HSP30 accumulation in A6 cells 
• To examine the effects of WA on cytoskeleton organization  





2 Materials and methods 
2.1 Culturing of Xenopus laevis A6 kidney epithelial cells 
The Xenopus laevis A6 kidney epithelial cell line (CCL-102; American Type Culture 
Collection (ATCC), Rockville, MD) were maintained as described in Phang et al. (1999). 
Cells were cultured at 22 °C in 55% Leibovitz (L)-15 media (Sigma-Aldrich, Oakville, ON) 
supplemented with 10% (v/v) fetal bovine serum (Sigma), 100 U/mL penicillin and 100 
µg/mL streptomycin (Sigma-Aldrich) in T75 cm2 BD Falcon tissue culture flasks (VWR 
International, Mississauga, ON). When cells reached confluence, old media was removed by 
aspiration, 2 ml of Versene [0.02% (w/v) KCl, (0.8% (w/v) NaCl, 0.02% (w/v) KH2PO4, 
0.115% (w/v) Na2HPO4, 0.02% (w/v) Na2EDTA] was added to the flasks for 2 min and then 
aspirated off. Cells were lifted off the surface of the flask using 1 ml of 1 X trypsin (Sigma) 
in 100% Hank’s balanced salt solution (HBSS; Sigma) for approximately 30 sec and then 
removed by aspiration. Free cells were resuspended in fresh media and then distributed 
evenly into additional tissue culture flasks. Cell treatments on the A6 cell line were 
performed with cells that reached 90-100% confluence. 
2.2 Treatment of Xenopus A6 kidney epithelial cells 
Withaferin A ( ≥ 99% purity; Enzo Life Sciences, Plymouth Meeting, PA) was 
dissolved in dimethylsulphoxide (DMSO; Sigma) to make a stock solution of 2.21 mM 
which was aliquoted and stored at -20 °C. This working stock was used to prepare 2, 5, or 10 
µM concentrations of withaferin A used for subsequent experiments. MG132 (Sigma) and 
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KNK437 (N-formyl-3, 4-methylenedioxy-benzylidene-γ-butyrolactam; Calbiochem, 
Gibbstown, NJ) were also dissolved in DMSO to prepare 5 mg/mL stock solutions. 
Experiments with MG132 used 30 µM concentrations while all treatments with KNK437 
used 100 µM concentrations. Appropriate volumes of each chemical were added to fresh L-
15 media followed by gentle shaking to ensure even distribution prior to adding each 
treatment to tissue culture flasks containing A6 cells. Cells treated with 5 µM WA for 2 h 
were allowed to recover for 2 h in withaferin A-free L-15 media. Treatments with 100 µM 
KNK437 were performed 6 h prior to treatment with 5 µM withaferin A. KNK437 at a 
concentration of 100 µM was employed in a number of previous studies to suppress hsp gene 
expression by inhibiting HSF1–HSE binding activity in mouse, human and Xenopus A6 cells 
with no detectable effect on cell viability (Ohnishi et al., 2004; Manwell and Heikkila, 2007; 
Takahashi et al., 2008; Voyer and Heikkila, 2008; Young and Heikkila, 2010). Some flasks 
of A6 cells were heat shocked for 4, 8 or 12 h in a water bath set at 30 °C. Heat shock 
treatments at 33 °C were for 2 h in a water bath set to the appropriate temperature, followed 
by a 2 h recovery period at 22 °C. 
2.3 Harvesting of A6 epithelial cells 
Immediately following treatment, media was aspirated off flasks containing treated 
A6 cells and 2 mL of 65% HBSS was added to rinse the cells. The cells were then removed 
with a cell scraper, suspended in 1 mL of 100% HBSS and transferred to a 1.5 ml 
microcentrifuge tube. After the cells were pelleted by centrifugation for 1 min at 16, 000 g, 
the supernatant was removed and cells were stored at -80 °C until protein or RNA isolation.  
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2.4 Detection of chymotrypsin-like activity 
Chymotrypsin-like activity was detected from cultured A6 cells using the Promega 
Proteasome-Glo cell based luminescent assay kit (Promega Corp., Madison, WI). The 
Proteasome-Glo cell-based reagents each contain a specific luminogenic proteasome 
substrate (Suc-LLVY-Glo substrate for chymotrypsin-like activity) in a buffer optimized for 
cell permeabilization, proteasome activity and luciferase activity. Proteasomal cleavage of 
the luminogenic molecule generates an aminoluciferin substrate that is consumed by 
luciferase to produce a luminescent signal at a rate proportional to chymotrypsin-like activity 
(Promega Corp., 2009).  Thawed Proteasome-Glo cell based buffer, lyophilized luciferin 
detection reagent and Suc-LLVY-Glo substrate were all equilibrated to room temperature in 
the dark. Once at room temperature the lyophilized luciferin detection buffer was 
reconstituted in Proteasome-Glo cell based buffer in an amber bottle provided by the 
manufacturer. Then 50 µL of the Suc-LLVY-Glo substrate was vortexed to remove any 
precipitate that may have formed. The substrate was then added to the amber bottle 
containing lyophilized luciferin detection reagent reconstituted in Proteasome-Glo cell based 
buffer. To remove any free aminoluciferin and reduce background luminescence, the 
contents of the bottle (prepared proteasome-glo cell based reagent) were then mixed gently 
and stored at room temperature in the dark for 30 min before use. 
Following WA or MG132 treatments, cells were washed with 2 mL of versene and 
then detached from the flask with 1 mL of 1 X trypsin. Nine mL of fresh L-15 media was 
then added to the flask and pipetted up and down to rinse the flask surface and allow for even 
distribution. The cell suspension was then transferred to a 15 mL Falcon tube. Cells were 
pelleted at 4 °C by gentle centrifugation at 1, 500 g for 5 min. Following centrifugation the 
 32 
media was removed by aspiration and pellets were washed in 5 mL of fresh L-15 media to 
remove any trypsin residue and then centrifuged again at 1, 5000 g for 5 min at 4 °C. A6 
cells were then resuspended in 5 mL of fresh L-15 media. For each sample, the total number 
of cells per mL was determined using a Bright-Line haemocytometer (Hausser Scientific, 
Horsham, PA). Approximately 15,000 were suspended in 100 µL of L-15 media for the 
proteasome-glo cell based assay. 
For the chymotrypsin-like activity assay, 100 µL of each sample was added to the 
wells of a white-walled 96-well plate. Then 100 µL of Proteasome-Glo cell-based reagent 
(prepared previously) was added to each sample-containing well. The plate contents were 
mixed gently in the dark by placing the plate on a rocking platform for 2 min. The samples 
were then incubated at room temperature for 45 min in the dark, prior to measuring 
chymotrypsin-like activity. The luminescence of each sample was measured using the 
Victor3 luminometer at 430 nm (PerkinElmer Inc., Waltham, MA). Values were then 
compared to a blank sample (Proteasome-Glo cell-based reagent + L-15 media) and a 
control-treated sample (Proteasome-Glo cell-based reagent + cells treated with DMSO).  
 
2.5 Protein Isolation and Western Blot Analysis 
2.5.1 Protein Isolation from A6 Cells 
A6 cell pellets were homogenized with 500 µL of lysis buffer (200 mM sucrose, 2 
mM EGTA, 1 mM EDTA, 40 mMNaCl, 30 mM HEPES, pH 7.4) containing 1% (w/v) SDS, 
1% (w/v) protease inhibitor cocktail (Roche) then sonicated on ice for 15-1 s pulses at 3.5 
output using a sonic dismembranator (Model 100, Fisher Scientific, Waltham, MA). It should 
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be noted that the lysis buffer used for samples in preparation for immunoblotting with a 
mouse anti-ubiquitin antibody contained 10 mM N-ethylmaleimide (NEM; Sigma) to 
facilitate the recovery of ubiquitinated protein. Isopeptidases hydrolyze the ubiquitin chain 
from ubiquitinated proteins and are dependent on active-site cysteinyl residues, which can be 
inactivated with thiol-blocking compounds such as NEM (Stipanuk et al., 2003). Protein was 
separated from the cellular debris by centrifugation at 20 800 g for 60 min at 4 °C in an 
Eppendorf Centrifuge 5810R. After centrifugation, supernatants were transferred to new 1.5 
ml microcentrifuge tubes and stored at –20 °C. 
2.5.2 Protein Quantification 
The concentrations of all isolated proteins were calculated using a bicinchoninic acid 
(BCA) protein assay (Pierce, Rockford, IL, USA). Dilutions of bovine serum albumin (BSA; 
Bioshop, Burlington, ON) ranging from 0 to 2 mg/ml were prepared in distilled water from a 
2 mg/ml stock. Aliquots of isolated protein samples were diluted 1:2 in distilled water and 10 
 µl of each BSA standard and protein sample was loaded onto a 96 well assay plate in 
triplicate. A 50:1 mixture of BCA reagent A to reagent B (Pierce) was prepared and 80 µl of 
the mixture was added to each well. The plate was incubated at 37 °C for 30 min then read at 
562 nm using a Versamax Tunable microplate reader (Molecular Devices, Sunnyvale, CA) 
and the Soft Max Pro software. The BSA standards were used to construct a standard curve 
in Microsoft Excel that was in turn used to determine the concentration of protein for each 
sample. 
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2.5.3 Western blot analysis 
 Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) employing 
10 -12% polyacrylamide gels was performed using a BioRad Mini Protean III gel system 
(BioRad, Mississauga, ON). Separating gels [10% (v/v) acrylamide, 0.27% (v/v) n’n’-
bismethyleneacrylamide, 0.375 M Tris pH 8.8, 0.1% (w/v) SDS, 0.05% (w/v) ammonium 
persulfate (APS), 0.1 5% (v/v) n,n,n’n’- Tetramethylethylenediamine (TEMED)] were 
prepared, poured and allowed to polymerize with a 100% ethanol overlay for 30 min. The 
ethanol layer was then removed and stacking gels [4% (v/v) acrylamide, 0.11% (v/v) n’n'-
bismethyleneacrylamide, 0.125 M Tris pH 6.8, 0.1% (w/v) SDS, 0.05% (w/v) APS, 0.2% 
(v/v) TEMED] were layered on top. Gels were allowed to polymerize for another 30 min 
with combs inserted to create wells. During gel polymerization, protein samples were 
aliquoted with 20 – 60 µg of protein and added to loading buffer [0.0625 M Tris pH 6.8, 10% 
(v/v) glycerol, 2% (w/v) SDS, 5% (v/v) β-mercaptoethanol, 0.00125% (w/v) bromophenol 
blue] to a final concentration of 1 X. All protein samples and protein markers were boiled for 
10 min, cooled on ice for 5 min then pulse-spun (6 sec at 9, 000 rpm) in a microcentrifuge 
before loading into the gel. Gels were electrophoresed with 1 X electrophoresis buffer [25 
mM Tris, 0.2 M glycine, 1 mM SDS] at 90 V until the dye reached the separating gel. 
Electrophoresis was then continued at 150-160 V until the dye front reached the bottom of 
the gel.  
 During electrophoresesis, pure nitrocellulose transfer blot membranes (BioRad) and 
filter paper (BioRad) were cut to 5.5 cm x 8.5 cm, and membranes were equilibrated in 
transfer buffer [25 mM Tris, 192 mM glycine, 20% (v/v) methanol] for 30 min. Following 
electrophoresis, the stacking gel was cut away and the remaining gel was soaked in transfer 
 35 
buffer for 10-15 min. Proteins were transferred to the nitrocellulose membrane using a Trans-
Blot Semi-dry Transfer Cell (BioRad) at 20 V for 25 min. After transfer, blots were stained 
with Ponceau-S stain [0.19% (w/v) Ponceau-S, 5% (v/v) acetic acid] for 10 min to determine 
efficiency of transfer, rinsed twice in water and then scanned with a Hewlett Packard ScanJet 
3300C. Blots were then incubated in 5% blocking solution [20 mM Tris (pH 7.5), 0.1% 
Tween 20 (Sigma), 300 mM NaCl, 5% (w/v) Nestle® Carnation skim milk powder] for 1 h at 
room temperature. The blocking solution was then replaced with primary antibody in 5% 
blocking solution for 1 h at room temperature. The antibodies used were either mouse anti-
ubiquitin (Zymed, San Francisco, CA), rabbit anti-HSP30 (Fernando and Heikkila, 2000), 
anti-HSP70 (Gauley and Heikkila) or anti-actin (Sigma) antibodies, prepared for Xenopus at 
dilutions of 1:150; 1:1000, 1:250 and 1:200, respectively. Membranes were washed with 1 X 
Tris-buffered saline with Tween 20 (TBS-T) [20 mM Tris, 300 mM NaCl, (pH 7.5), 0.1% 
Tween 20 (Sigma)] once for 15 min and then twice for 10 min to remove excess unbound 
antibody. Blots were incubated with the secondary antibody conjugate, AP-conjugated goat-
anti-rabbit (BioRad) at a 1:3000 dilution or AP-conjugated goat-anti-mouse (BioRad) at a 
1:1000 dilution in 5% blocking solution for 1 h. The membranes were washed with fresh 
TBS-T once for 15 min and then twice for 5 min. For detection, the blots were immersed in 
alkaline phosphatase detection buffer (50 mM Tris, 50 mM NaCl, 25 mM MgCl2, pH 9.5) 
with 0.33% nitrobluetetrazolium chloride (NBT; Roche) and 0.17% 5-bromo- 4-chloro-3-
indolyl phosphate, toluidine salt (BCIP; Roche) until the bands were visible, then removed 
before saturation of the bands occurred. Images were scanned using a Hewlett Packard 
ScanJet 3300C. 
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2.5.4 Densitometric statistical analysis 
Densitometric analyses were performed in triplicate of appropriately stained blots 
(within the range of signal linearity) using ImageJ (Version 1.38) software. In using this 
software, equal sized boxes were drawn around all protein bands detected with ant-HSP30, 
anti-HSP70 or anti-ubiquitin. Average densitometric values were expressed as a percentage 
of the maximum hybridization band or as percent inhibition for KNK437 experiments. The 
data were graphed with standard error represented as vertical error bars. The level of 
significance of the differences between the samples was calculated using one-way analysis of 
variance (ANOVA) with a Tukey's post-test. Confidence levels used were 95% (p<0.05) or 
90% (p<0.1) as indicated. 
2.6 Immunocytochemistry and laser scanning confocal microscopy 
For immunofluorescence analysis, A6 cells were grown on glass coverslips in Petri 
dishes. Coverslips were first base washed in small staining jars (Thomas Scientific 
Apparatus, Philadelphia, PA) to ensure full contact with the base solution [49.5% (v/v) 
ethanol, 0.22 M NaOH] for 30 min with periodic shaking at room temperature. The 
coverslips were then rinsed with running distilled water for 3 h and dried on 3MM Whatman 
paper. Finally, the coverslips were flame sterilized in the laminar flow hood then placed in 
new sterile Petri dishes. A6 cell suspension was added to the Petri plate and allowed to attach 
for 24 h at 22 °C. For WA treatments, cells were treated directly in the Petri dishes at 22 °C. 
In heat shock experiments, the Petri dishes were wrapped with parafilm® (Pechiney Plastic 
Packaging, Menasha, WI), sealed in a plastic bag and then placed in a heated water bath. 
Following treatment, the L-15 media was removed and the cells were rinsed twice in 
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phosphate-buffered saline (PBS; 1.37 M NaCl, 67 mM Na2HPO4, 26 mM KCl, 14.7 mM 
H2PO4, 1 mM CaCl2, 0.5 mM MgCl2, pH 7.4) and the coverslips were transferred to new 
small Petri dishes. Cells were then fixed in 3.7% paraformaldehyde (BDH, Toronto, ON) for 
15 min followed by three washes with PBS for 5 min each. After permeabilized with 0.3% 
Triton X-100 (Sigma- Aldrich) in PBS for 10 min, cells were rinsed three times with PBS for 
5 min. Cells were then incubated with 3.7% bovine serum albumin fraction V (BSA fraction 
V; FisherScientific, Ottawa, ON) for 1 h at room temperature or overnight at 4 °C followed 
by with affinity-purified rabbit anti-Xenopus HSP30 antibody (1:500) in 3.7% BSA for 1 h.  
BSA fraction V was filter-sterilized with a 0.45 µm filter to remove particulate that might 
affect image quality before use. Three washes for 3 min each in PBS, was followed by 
indirect labeling of cells with a fluorescent-conjugated secondary antibody, goat anti-rabbit 
Alexa Fluor 488 (Molecular Probes, Eugene, OR), at 1:2000 in 3.7% BSA for 30 min in the 
dark. The cells were subsequently probed for F-actin with rhodamine-tetramethylrhodamine- 
5-isothiocyanate phalloidin conjugated TRITC (Molecular Probes) at 1:60 in PBS for 15 min 
in the dark followed by three PBS washes for 5 min each. Coverslips were mounted on glass 
slides with VectaShield mounting media containing 4,6-diamidino-2-phenylindole (DAPI; 
Vector Laboratories Inc., Burlingame, CA), which stains nucleic acids allowing visualization 
of nuclei. Coverslips were permanently attached and sealed to slides using clear nail polish 
and then stored at 4 °C for no longer than three weeks. Slides were evaluated by laser 
scanning confocal microscopy (LSCM) using a Zeiss Axiovert 200 microscope and LSM 510 
META software (Carl Zeiss Canada Ltd., Mississauga, ON) and the 63 X oil objective. The 
multi-channel configuration was used to collect emission spectra for DAPI (405), Alexa 488 
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(488 nm), and TRITC (533 nm) on multiple tracks to minimize cross-channel contamination 
of fluorescence emissions. 
2.7 Antisense riboprobe production and northern blot hybridization analysis 
2.7.1 hsp30C template construction 
Previously in our laboratory, the coding region of hsp30C genomic DNA was inserted 
into the pRSET expression vector (Invitrogen, Carlsbad, CA) by Pasan Fernando (Fernando 
and Heikkila, 2000). Plasmids containing the hsp30C insert were then transformed into 
Escherichia coli DH5α cells where individual colonies were inoculated in 5 mL of LB broth 
[1% (w/v) tryptone-peptone, 0.5% (w/v) yeast extract, 1% (w/v) NaCl, pH 7.5] containing 
100 µg/ml ampicillin (Bioshop, Burlington, ON) and grown overnight at 37 °C for 14-16 h 
with vigorous shaking.  
2.7.2 hsp70 template construction 
The open reading frame of the hsp70 gene was previously isolated (Lang et al., 2000) 
and inserted into the plasmid pSP72 (Promega, Napean, ON). Plasmids containing the hsp70 
insert were also inoculated in 5 mL of LB broth containing 100 ìg/ml ampicillin and grown 
overnight at 37 °C for 14-16 h. 
2.7.3 Isolation of plasmid DNA 
After overnight incubation, bacterial cells were collected by centrifugation 
(Eppendorf Centrifuge 5810R; Brinkmann Instruments Ltd., Mississauga, ON) at 2, 600 g for 
5 min at 4 °C. After removing the media, pelleted cells were resuspended in 200 µl of ice-
cold alkaline lyisis solution #1 [50 mM glucose, 25 mM Tris (pH 8.0) and 1 mM EDTA (pH 
 39 
8.0)] and then transferred into a microcentrifuge tube. The cells were lysed by gentle mixing 
with 200 µl of alkaline lysis solution #2 [0.2 M NaOH and 1% (w/v) SDS (sodium dodecyl 
sulfate)]. The microcentrifuge tubes were kept on ice for the remainder of the protocol. After 
adding 200 µl of ice-cold alkaline solution #3 [3 M potassium acetate and 5 M glacial acetic 
acid] the tubes were mixed gently and placed on ice for 5 min. To separate cellular debris, 
the samples were centrifuged at 20, 800 g for 5 min at 4 °C and the supernatant was 
transferred to fresh microcentrifuge tubes. This was followed by RNase A treatment (10 
µg/mL; BioShop, Burlington, ON) for 1 h at 37 °C to remove unwanted RNA from the 
samples.  
After removing samples from the 37 °C water bath, 600 µl of phenol:chloroform (1:1) 
was added and the samples were mixed by vortexing then centrifuged at 20, 800 g for 3 min 
at 4 °C.  The upper aqueous layer was transferred to new microcentrifuge tubes to which 600 
µL of isoamyl alcohol:chloroform (1:24) was added These samples were then vortexed and 
centrifuged at 20, 800 g for 3 min at 4 °C. Again the upper aqueous layer was transferred to 
fresh microcentrifuge tubes. To precipitate the nucleic acids, 600 µl of isopropanol was 
added to each microcentrifuge tube. The samples were then mixed by vortexing and allowed 
to stand at room temperature for 2 min, followed by centrifugation at 20, 800 g for 5 min at 
room temperature. The supernatant was gently removed and 1 ml of 70% ethanol was added 
to wash the pellets. The samples were then centrifuged at 20, 800 g for 2 min at 4 °C. Then 
the ethanol was removed and the previous step was repeated. The pellets were allowed to air 
dry and then resuspended in 50 µl distilled water and stored at -20 °C. 
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2.7.4 In vitro transcription 
The isolated plasmid containing the hsp30C or hsp70 insert as mentioned above was 
linearized using the PvuII or MluNI restriction enzymes, respectively (Roche, Laval, QU). 
The linearized plasmids were then electrophoresed on a 1% (w/v) agarose gel in 1 X 
modified tris-acetate EDTA buffer (TAE; Millipore corp., Bedford, MA). The DNA band 
corresponding to the hsp30C or hsp70 insert, when compared to size standards, was 
visualized using a UV lamp. The DNA band was excised from the gel using a razor blade. 
Plasmid DNA was collected from the gel using the Montage DNA gel Extraction Kit 
(Millipore). The gel slice containing the plasmid DNA was placed into a gel nebulizer, 
containing a microporous membrane filter (Millipore), which was then centrifuged at 5, 000 
g for 10 min at 4 °C. The filter was removed and 100% ice-cold filtered ethanol (2x volume) 
and 3 M sodium acetate (pH 5.2, 1/10 volume) were added to precipitate the DNA. The tube 
was then placed at -20 °C for 30 min followed by centrifugation at 20, 800 g for 10 min at 4 
°C. After the supernatant was discarded, the pellet was washed twice with 1 ml of 70% ice-
cold filtered ethanol and centrifuged at 20, 800 g for 10 min at 4 °C. The ethanol was then 
discarded and the pellet was air dried and resuspended in 20 µl of sterile water and stored at -
20 °C.  
In vitro transcription was used to generate digoxygenin (DIG)-labelled riboprobes. 
Each in vitro transcription reaction containing 4 µl of linearized DNA template, 4 µl of rNTP 
mix [2.5 mM rGTP, 2.5 mM rATP, 2.5 mM rCTP, 1.625 mM rUTP (Promega, Nepean, ON), 
0.875 mM DIG-11-UTP (Roche), 1.5 µl diethylpyrocarbonate (DEPC, Sigma)-treated water, 
4 µl of 100 mM diatholthreitol (DTT; Promega), 4 µl of 5 X transcription buffer (Fermentas, 
Burlington, ON), 0.5 µl RNase inhibitor (Fermentas) and 40 IU of SP6 RNA polymerase 
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(Roche)], was carried out in a 1.5 ml microcentrifuge tube for 1 h at 37 °C. To remove any 
remaining DNA template, reactions were incubated with 2 µl of RNase-free DNase 1 
(Roche) for 10 min at 37 °C. In vitro transcripts were then precipitated by the addition of 10 
µl of 3 M sodium acetate (pH 5.2), 80 µl of TES [10 mM Tris-HCl (pH 7.4), 5 mM EDTA 
(pH 8.0), 1% (w/v) SDS] and 220 µl of ice-cold 100% filtered ethanol. The reaction was 
incubated at -80 ˚C for 30 min and then centrifuged at 20, 800 g for 15 min at 4 °C. After the 
supernatant was removed and the pellet was air-dried the RNA was resuspended in 21 µl of 
DEPC-treated water and stored at -80 °C until use in northern blot hybridization analysis. 
Two µl of the sample was electrophoresed to verify the presence of the in vitro transcript.  
2.7.5 RNA isolation 
RNA was isolated from pelleted A6 cells using the Qiagen RNeasy Mini Kit (Qiagen, 
Mississauga, ON) according to the manufacturer’s protocol outlined in the RNeasy Mini 
Handbook (2009). Isolated RNA was suspended in 30 µl of DEPC-treated water and 
quantified using the NanoDrop ND-1000 (NanoDrop, Waltham, MA) spectrophotometer. 
RNA integrity was evaluated by electrophoresis using 2 µg of each RNA sample on a 1.2% 
formaldehyde agarose gel [1.2% (w/v) agarose, 10% (v/v) 10 X MOPS, 16% (v/v) 
formaldehyde]. Samples were prepare for electrophoresis by the addition of 10 µl of loading 
buffer [1 µl 10 X MOPS, 1.6 µl formaldehyde, 2 µl RNA loading dye (0.2% bromophenol 
blue, 1 mM EDTA (pH 8.0), 50% (v/v) glycerol), 5 µl formamide, 0.5 µg/ml ethidium 
bromide] followed by heat denaturation in a 68 °C water bath for 10 min then immediately 
cooled on ice for 5 min. The samples were then electrophoresed at 90-100 V for 
approximately 1 h. 
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2.7.6 Northern blot hybridization analysis 
Ten µg of each RNA sample was separated by 1.2% formaldehyde agarose gel 
electrophoresis as previously described with the following exceptions. Ethidium bromide was 
omitted from the loading buffer and the gel was electrophoresed for 3-4 h at 90 V. Following 
electrophoresis the gel was soaked in 0.05 NaOH for 20 min at room temperature to denature 
the RNA. Next, the gel was rinsed in DEPC-treated water and soaked twice for 20 min each 
in fresh 20 X SSC buffer [3 M sodium chloride, 300 mM sodium citrate]. The RNA was then 
transferred overnight to a positively charged nylon membrane (Roche) by capillary action as 
described below. A piece of SSC pre-soaked 3MM Whatman filter paper was placed on a 
plexiglass support over a Pyrex® dish containing approximately 500 mL of 20 X SSC to act 
as a wick. The gel was inverted onto the wick, then topped with an appropriate sized piece of 
nylon membrane and two pieces of 3MM Whatman filter paper. Paper towels were next 
stacked about 7-8 cm high on top of the filter paper followed by a plexiglass support and a 
weight of approximately 250 g to aid transfer. The wick was covered in parafilm® to avoid 
excessive evaporation. Following transfer, the RNA was UV-crosslinked twice to the 
membrane using a UVC-515 Ultraviolet Multilinker (UltraLum Inc., Claremont, CA) at 
12,000 MicroJ/CM2. The membrane was then soaked in 10% (v/v) glacial acetic acid for 5 
min before staining with 1 X Blue Reversible Northern Blot Staining Solution (Sigma) for 10 
min to assess the quality of the transfer. After rinsing with DEPC-treated water, the stained 
membrane was scanned using a Hewlett Packard ScanJet 3300C.  
The membrane was then incubated in 50 ml of pre-heated prehybridization buffer 
[50% (v/v) formamide, 5 X SSC, 0.02% (w/v) SDS, 0.01% (w/v) N-laurylsarcosine, 2% 
(w/v) blocking reagent (Roche)] in a hybridization bag at 68 °C for 4 h in a pre-heated 
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hybridization oven (Boekel Scientific, Feasterville, PA). Prehybridization buffer was 
replaced with hybridization buffer (same components as prehybridization buffer) containing 
20 µl of either hsp30 or hsp70 DIG-labelled antisense riboprobe. The membrane was 
returned to the hybridization oven and incubated overnight at 68 °C.  
Following hybridization, any unbound probe was removed by washing the membrane. 
Initially, the membrane was washed twice in 2 X SSC with 0.1% (w/v) SDS at room 
temperature for 5 min. This was followed by a 15 min wash in 0.5 X SSC and 0.1% (w/v) 
SDS at 68 °C then a 15 min wash in 0.1 X SSC and 0.1% (w/v) SDS at 68 °C. The blot was 
then equilibrated for 1 min at room temperature in washing buffer [100 mM maleic acid 
buffer, 0.3% (v/v) Tween-20] then blocked using blocking solution [2% (w/v) blocking 
reagent (Roche), 10% (v/v) maleic acid buffer] for 1 h at room temperature. After blocking, 
the membrane was incubated in blocking solution containing 1:8000 alkaline phosphatase 
conjugated anti-DIG-Fab fragments (Roche) for 30 min. After the membrane was washed 
twice in washing buffer for 10 min each, it was equilibrated in detection buffer [0.1 M Tris-
HCl (pH 9.5), 0.1 M NaCl] for 2 min. CDP-star (Roche), a chemiluminescent reagent, which 
was applied to the membrane and allowed to develop in a hybridization bag for 10 min in the 
dark. Bound probe was detected using a DNR Chemiluminescent Imager (DNR Bioimaging 
Systems, Kirkland, QU) with the enzymatic chemiluminescence (ECL) plate for up to 12 min 
depending on the strength of the signal. 
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3 Results  
3.1 Inhibition of Proteasome Activity by WA in A6 cells 
Previous studies suggested that WA inhibited proteasome activity in mammalian cells 
(Yang et al., 2007). The impact of WA on proteasome activity in Xenopus laevis A6 cells 
was determined by examining the relative levels of ubiquitinated protein and chymotrypsin-
like activity. The relative level of ubiquitinated protein in A6 cells treated with 5 µM WA for 
4 h, as determined by immunoblot analysis using an anti-ubiquitin antibody, was not 
significantly enhanced compared to control cells (Fig. 4a). However, densitometric analysis 
(Fig. 4b) revealed that cells exposed to 5 µM WA for 18h exhibited a 2-fold increase in the 
relative levels of ubiquitinated protein, compared to control treated cells. These results are 
comparable to those observed with the proteasome inhibitor MG132, previously 
characterized in Xenopus laevis A6 cells (Young and Heikkila, 2010). Chymotrypsin-like 
activity of WA-treated A6 cells was determined by means of a cell-based assay. 
Chymotrypsin-like activity decreased by approximately 45% and 70% in A6 cells treated 
with 5 µM WA for 4 and 18 h, respectively, compared to control cells (Fig. 5). Similar 
results were obtained with cells subjected to different concentrations of WA for 18 h. A6 
cells exposed to 2 and 5 µM WA exhibited a 38% and 80% decrease in chymotrypsin-like 
activity, respectively, compared to controls (Fig. 6). In comparison, treatment of cells with 30 
µM MG132, a proteasome inhibitor, displayed an 83% to 98% reduction in chymotrypsin-




Figure 4. Effect of WA on the relative levels of ubiquitinated protein (Ub) in A6 kidney 
epithelial cells. A) Cells were maintained at 22 °C and treated with DMSO (C) or with 5 µM 
WA for 4 or 18 h. After treatment, cells were harvested and total protein was transferred to 
nitrocellulose membranes from SDS-polyacrylamide gels and probed with a mouse anti-
ubiquitin monocolonal antibody as described in Materials and methods. The positions of 
molecular mass standards in kDa are shown in the first lane (M). A sample of a 
representative Ponceau S stained membrane (lower panel) that brackets a 42-kDa band (*) is 
included to demonstrate efficient protein transfer. B) Image J software was used to perform 
densitometric analysis of the signal intensity for protein of the immunoblots as described in 
Materials and methods. The data are expressed as a percentage of the maximum band while 
the standard error is represented by vertical error bars. The level of significance of the 
differences between samples was calculated by one-way ANOVA with a Tukey’s post-test. 
Significant differences between control (C) and cells exposed to 5 µM WA for 18 h are 









Figure 5. Inhibition of chymotrypsin-like activity of A6 cells treated with WA for 4 and 
18 h. A6 cells were maintained at 22 °C and incubated with DMSO (C), or with 5 µM WA 
for 4 or 18 h or 30 µM MG132 for 18 h. The relative levels of chymotrypsin (CT)-like 
activity were determined and expressed as a percentage of control while the standard error is 
represented by vertical error bars. The level of significance of the differences between 
samples was calculated by one-way ANOVA with a Tukey’s post-test. Significant 
differences between control cells and A6 cells treated with MG132 or WA are indicated as * 












Figure 6. Inhibition of chymotrypsin-like activity in A6 cells treated with 2 and 5 µM 
WA. Cells were maintained at 22 °C and incubated with DMSO (C) or with 2, or 5 µM WA 
or 30 µM MG132 for 18 h. The relative levels of chymotrypsin (CT)-like activity were 
determined and expressed as a percentage of control while the standard error is represented 
by vertical error bars. The level of significance of the differences between samples was 
calculated by one-way ANOVA with a Tukey’s post-test. Significant differences between 
control cells and A6 cells treated with MG132 or WA are indicated as * (p<0.05). These data 










3.2 Effect of WA on HSP30 and HSP70 accumulation 
Accumulation of HSP30 and HSP70 in response to WA treatment was determined by 
immunoblot analysis using anti-Xenopus HSP30 and anti-Xenopus HSP70 polyclonal 
antibodies. These antibodies were previously used to detect HSP30 and HSP70 accumulation 
in A6 cells in  response to a variety of stressors including heat shock (Young et al., 2009; 
Walcott and Heikkila, 2010; Young and Heikkila, 2010). Figure 7 displays a typical result in 
which the relative levels of HSP30 and HSP70 were enhanced in A6 cells treated with a 33 
°C heat shock compared to cells maintained at 22 °C. The effect of different concentrations 
of WA on HSP accumulation in A6 cells is shown in Figure 8. Maximal accumulation of 
HSP30 was detected in cells incubated for 18 h with 5 µM WA and levels remained elevated 
at 10 µM WA. Compared to cells treated with 2 µM WA, exposure to 5 and 10 µM WA, 
resulted in an 11- and 10-fold increase, respectively, in HSP30 accumulation. In contrast, 
cells exposed to 2 µM and 5 µM WA for 18 h exhibited an 8-fold increase in HSP70 
accumulation, compared to control. The multiple protein bands observed in Figure 8a (top 
panel) may represent additional HSP30 family members that are detected by the anti-HSP30 
antibody. In addition, variation in the relative intensity exists with respect to the different 
HSP30 bands. As WA concentration increased, the intensity of the top band increased while 
the intensity of the lower band decreases. The cause of this is not known, however, variations 
in the accumulation of HSP30 family members or post-translational modifications may exist 









Figure 7. Effect of heat shock on HSP30 and HSP70 accumulation in A6 cells. Cells were 
maintained at 22 °C or heat shocked at 33 °C for 2 h with a 2 h recovery at 22 °C. After 
treatment, cells were harvested and total protein was isolated and subjected to immunoblot 
analysis employing anti-HSP30, anti-HSP70 or anti-actin polyclonal antibodies. These data 












Figure 8. Effect of different concentrations of WA on HSP30 and HSP70 accumulation 
in A6 cells. A) Cells were maintained at 22 °C and treated with DMSO (C) or 2, 5 or 10 µM 
WA for 18 h. Total protein was isolated and subjected to immunoblot analysis employing 
anti-HSP30, anti-HSP70 or anti-actin polyclonal antibodies. B) Image J software was used to 
perform densitometric analysis of the signal intensity for HSP30 (grey) and HSP70 (outline) 
protein bands of the immunoblots as described in Materials and methods. The data are 
expressed as a percentage of the maximum band (5 µM WA or 10 µM WA for HSP30 and 5 
µM for HSP70) while the standard error is represented by vertical error bars. The level of 
significance of the differences between samples was calculated by one-way ANOVA with a 
Tukey’s post-test. Significant differences between control (C) and 5 and 10 µM WA are 
indicated as * (p<0.05). These data are representative of three separate experiments.  
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of phosphorylation as HSP30 was only found to be mono-phosphorylated by MAPKAPK-2, 
adding approximately 79 Da to its size, which cannot be separated by the SDS-PAGE 
protocol used in this experiment. To further explore this possibility, additional HSP30 post-
translational modifications should be examined. Densitometric analysis also revealed that in 
cells treated with 10 µM WA for 18 h HSP70 accumulation decreased 20% compared to cells 
treated with 5 µM WA.  
In time course studies, immunoblot analysis revealed that HSP30 and HSP70 levels 
gradually increased with extended incubation time up to 24 h in A6 cells exposed to 5 µM 
WA (Fig. 9). A significant increase (p<0.05) of 31% and 52% in the relative levels of HSP30 
and HSP70, respectively, occurred in cells treated with 5 µM WA for 8 h compared to 
control.   
3.3 Analysis of the regulation of WA-induced hsp30 and hsp70 gene 
expression 
Previous studies with Xenopus laevis A6 cells indicated that induction of hsp genes 
by various stressors including heat shock, sodium arsenite, cadmium chloride, celastrol and 
MG132 were regulated, at least in part, at the level of transcription (Manwell and Heikkila, 
2007; Voyer and Heikkila, 2008, Young et al., 2009; Walcott and Heikkila, 2010; Young and 
Heikkila, 2010). HSF1-mediated hsp gene expression results in the synthesis of hsp mRNA. 
Northern blot hybridization analysis revealed that WA treatment induced the accumulation of 
both hsp30 and hsp70 mRNA. Relatively low levels of hsp30 and hsp70 mRNA were 
observed in cells exposed to 5 µM WA for 4 h, which increased with prolonged incubation 





Figure 9. Temporal pattern of HSP30 and HSP70 levels in A6 cells treated with WA. A) 
Cells were maintained at 22 °C or treated with 5 µM WA for 2 to 24 h. Total protein was 
isolated and subjected to immunoblot analysis employing anti-HSP30, anti-HSP70 and anti-
actin polyclonal antibodies. B) Image J software was used to perform densitometric analysis 
of the signal intensity for HSP30 (grey) and HSP70 (outline) protein bands of the 
immunoblots as described in Materials and methods. The data are expressed as a percentage 
of the maximum band (24 h and 18 h for HSP30 and HSP70, respectively). The standard 
error is represented by vertical error bars. The level of significance of the differences 
between samples was calculated by one-way ANOVA with a Tukey’s post-test. Significant 
differences between control (C) cells and WA treated cells are indicated as * (p<0.05). These 










Figure 10. hsp30 and hsp70 mRNA accumulation in A6 cells treated with WA. Cells 
were maintained at 22 ºC and incubated with DMSO (C) or exposed to 5µM WA for 4, 8 or 
12 h. Cells were harvested and total RNA was isolated and quantified. Total RNA (10 µg) 
was analysed by northern hybridization analysis using hsp30 and hsp70 antisense riboprobes. 
The bottom panel exhibits a reversible blot stain which confirms quality of transfer. These 








Additionally, KNK437, a HSF1 inhibitor, was utilized to determine if the WA-
induced hsp30 and hsp70 gene expression in A6 cells was due to HSF1 activation (Fig. 11). 
Cells were pretreated with 100 µM KNK437 for 6 h prior to exposure to 5 µM WA for 8, 12 
or 18 h. Immunoblot and subsequent densitometric analysis demonstrated that WA-induced 
HSP30 accumulation was inhibited in cells treated with WA for 8, 12 and 18 h by 95%, 90% 
and 98% respectively, compared to WA-treated cells without KNK437. Similarly, following 
pretreatment with KNK437, HSP70 levels decreased in cells incubated with WA for 8, 12 
and 18 h by 98%, 96% and 94%, respectively.  
3.4 The localization of HSP30 in A6 cells treated with WA 
The accumulation and intracellular localization of HSP30 induced by heat shock or 
WA treatment was analyzed by immunocytochemistry and laser scanning confocal 
microscopy (LSCM). The localization of HSP70 was not investigated since the anti-HSP70 
antibody, which was used successfully in immunoblot experiments, was unable to 
specifically detect HSP70 by immunocytochemistry. As shown in Figure 12, accumulation of 
HSP30 was not detected in control cells maintained at 22 °C or in cells treated with a 30 °C 
heat shock. However, HSP30 was detected in approximately 99% of A6 cells exposed to a 33 
°C heat shock. Treatment of cells with 5 µM WA for 8, 12 or 18 h resulted in the 
accumulation of HSP30 in approximately 20% of cells in a granular or punctate pattern 
primarily in the cytoplasm with a small amount in the nucleus (Fig. 13). Examination of the 





Figure 11. Effect of KNK437 on WA-induced HSP30 and HSP70 accumulation in A6 
cells. A) Cells were maintained at 22 °C, treated with DMSO (C), pretreated with 100 µM 
KNK437 for 6 h or treated with 5 µM WA for 8 – 18 h with or without 100 µM KNK 
pretreatment for 6 h. Total protein was isolated and analyzed by immunoblotting using anti-
HSP30, anti-HSP70 or anti-actin polyclonal antibodies. B) Densitometric analysis was 
performed, using Image J software, of the signal intensity for HSP30 (grey) and HSP70 
(outline) protein bands of the immunoblots. The data are expressed as percent inhibition of 
WA-induced HSP at each time point and the standard error is represented by vertical error 
bars. The level of significance of the differences between samples was calculated by one-way 
ANOVA with a Tukey’s post-test. Significant differences between cells exposed to WA with 
or without a 6 h KNK437 pretreatment are indicated as * (p<0.05) or Δ (p<0.1). These data 









Figure 12. Localization of HSP30 accumulation in A6 cells in response to heat shock. 
Cells were cultured on base-washed glass coverslips and maintained at 22 °C or heat shocked 
at 30 °C or 33 °C for 2 h followed by a 2 h recovery at 22 °C. Actin and nuclei were stained 
directly with phalloidin conjugated to TRITC (red) and DAPI (blue), respectively. HSP30 
was indirectly detected with an anti-HSP30 antibody and a secondary antibody conjugated to 
Alexa-488 (green). The 10 µM white scale bars are indicated at the bottom right section of 










Figure 13. Localization of WA-induced HSP30 accumulation in A6 cells. Cells were 
cultured on base-washed glass coverslips and maintained at 22 °C or incubated with 5 µM 
WA for 8, 12 or 18 h. Actin and nuclei were stained directly with phalloidin conjugated to 
TRITC (red) and DAPI (blue), respectively. HSP30 was indirectly detected with an anti-
HSP30 antibody and a secondary antibody conjugated to Alexa-488 (green). The white 
arrows indicate ruffled edges of the actin cytoskeleton. Actin aggregates are indicated by a 
yellow arrow, the pink arrows point to HSP30 associated foci and the yellow arrows with 
diamond ends indicate co-localization of actin aggregates and HSP30 associated foci. The 10 
µM white scale bars are indicated at the bottom right section of each panel. These data are 





displayed an intact cytoskeleton and visible stress fibres, similar to control cells. In contrast, 
cells treated with prolonged WA exposure displayed some actin disorganization. After 12 
and 18 h, WA-treated cells displayed distinct areas of actin aggregation, indicated by the 
yellow arrows. In addition, ruffled edges at the cellular periphery, resulted from exposure to 
WA for 18 h, as indicated by white arrows. Figure 14 displays an enlarged image of an A6 
cell treated with 5 µM WA for 18 h. Orange staining in the far right panel indicates areas of 
actin aggregation co-localized with large HSP30 associated granules. 
3.5 The effect of mild heat shock on WA-induced HSP30 and HSP70 
accumulation 
In previous studies, mild heat shock treatments enhanced sodium arsenite-, celastrol- 
and MG132-induced hsp gene expression in A6 cells (Young et al., 2009; Walcott and 
Heikkila, 2010; Young and Heikkila, 2010). In the present study, the effect of a mild heat 
shock temperature on WA-induced HSP30 and HSP70 accumulation was examined by 
immunoblot analysis. HSP30 accumulation was not detected in cells exposed singly to mild 
heat shock (30 °C) nor in cells treated with 2 µM WA for 8 h (Fig. 15). Similarly, low levels 
of HSP70 were detected in heat shock-treated and WA-treated cells. In contrast, concurrent 
treatment of mild heat shock with 2 µM WA, resulted in enhanced levels of HSP30 and 
HSP70 accumulation that was greater than the sum found with each stress individually. 
Compared to cells exposed singly to 2 µM WA and 30 °C, HSP30 accumulation increased, in 
cells treated with concurrent stress, by 99% and 98%, respectively and the level of HSP70 
increased 67% and 90%, respectively. Similarly, co-treatment with mild heat shock and 5 µM 







Figure 14. Co-localization of actin aggregates with HSP30 associated foci. Cells were 
cultured on base-washed glass coverslips and incubated with 5 µM WA for 18 h. Actin and 
nuclei were stained directly with phalloidin conjugated to TRITC (red) and DAPI (blue), 
respectively. HSP30 was indirectly detected with an anti-HSP30 antibody and a secondary 
antibody conjugated to Alexa-488 (green). Actin aggregates are indicated by a yellow arrow, 
the pink arrows point to HSP30 associated foci and the yellow arrows with diamond ends 
indicate co-localization of actin aggregates and HSP30 associated foci. The 5 µM white scale 
bars are indicated at the bottom right section of each panel. These data are representative of 











Figure 15. Effect of mild heat shock on WA-induced HSP30 and HSP70 accumulation 
in A6 cells. A) Cells were maintained at 22 °C and treated with DMSO (C), or exposed to 2 
or 5 µM WA singly or with a mild heat shock at 30 °C for 8h. Following treatment, cells 
were harvested and total protein isolated. Immunoblot analysis was performed using anti-
HSP30, anti-HSP70 and anti-actin polyclonal antibodies. B) Image J software was used to 
perform densitometric analysis of the signal intensity for HSP30 (grey) and HSP70 (outline) 
protein bands of the immunoblots as described in Materials and methods. The data are 
expressed as a percentage of the maximum band (combined WA and mild heat shock 
treatment) at each WA concentration. The standard error is represented by vertical error bars. 
The level of significance of the differences between samples was calculated by one-way 
ANOVA with a Tukey’s post-test. Significant differences between the maximum signal for 






and HSP70 (67% and 90%, respectively) compared to cells exposed to mild heat shock or 
WA alone.  
Additionally, time course studies showed elevated levels of HSP30 and HSP70 in A6 
cells treated with 5 µM WA and mild heat shock for 4, 8 and 12 h compared to each stressor 
individually (Fig. 16). Densitometric analysis revealed that HSP30 and HSP70 accumulation 
in cells treated with 5 µM WA at 30 °C was greater than the sum of either WA or mild heat 
shock alone at each time point. For example, compared to cells treated with either 5 µM WA 
or 30 °C for 4 h, cells exposed to both stressors simultaneously increased the level of HSP30 
by 14.5- and 26.3-fold, respectively. Similarly HSP70 accumulation in A6 cells treated 
concurrently with both stressors increased by 22.6- and 5.5-fold, respectively, compared to 
cells exposed to WA or mild heat shock alone. 
3.6 HSP30 localization in A6 cells exposed concurrently to WA and heat 
shock treatment 
The effect of heat shock on WA-induced HSP30 accumulation and localization in A6 
cells was examined by immunocytochemistry and LSCM. Cells were grown on base washed 
coverslips and maintained at 22 °C or incubated with 5 µM WA with or without heat shock  
(30 °C) for 8 h. HSP30 accumulation was not detected in cells exposed to a mild heat shock, 
while HSP30 was detected in approximately 20% of cells exposed to 5 µM WA for 8 h. An 
increase in HSP30 accumulation (approximately 99% of cells) was observed in A6 cells 
treated concurrently with 5 µM WA and mild heat shock, compared to either stressor alone 




Figure 16. Temporal pattern of HSP30 and HSP70 accumulation A6 cells treated 
concurrently with WA plus mild heat shock. A.) Cells were maintained at 22 °C and 
treated with DMSO (C), or exposed to 5 µM WA singly or with a mild heat shock at 30 °C 
for 4, 8 or 12 h.  Following treatment, cells were harvested and total protein isolated. 
Immunoblot analysis was performed using anti-HSP30, anti-HSP70 and anti-actin polyclonal 
antibodies. B) Image J software was used to perform densitometric analysis of the signal 
intensity for HSP30 (grey) and HSP70 (outline) protein bands of the immunoblots as 
described in Materials and methods. The data are expressed as a percentage of the maximum 
band (combined WA and mild heat shock treatment) at each time point. The standard error is 
represented by vertical error bars. The level of significance of the differences between 
samples was calculated by one-way ANOVA with a Tukey’s post-test. Significant 
differences between the maximum signal at each time point are indicated as * (p<0.05). 








Figure 17. Localization of HSP30 in A6 cells treated with concurrent stress. Cells were 
cultured on base-washed glass coverslips and maintained at 22 °C or 30 °C for 8 h or 
incubated with 5 µM WA for 8 h at 22 °C or 30 °C. Actin and nuclei were stained directly 
with phalloidin conjugated to TRITC (red) and DAPI (blue), respectively. HSP30 was 
indirectly detected with an anti-HSP30 antibody and a secondary antibody conjugated to 
Alexa-488 (green). The white arrows indicate ruffled edges of the actin cytoskeleton and the 
pink arrows point to HSP30 associated foci. The 10 µM white scale bars are indicated at the 






however a slight ruffling of the edges was present as indicated by white arrows. As well, 
large HSP30 associated aggregates or foci were observed in some cells exposed to concurrent 
WA and mild heat shock (pink arrows). Similar structures were observed in A6 cells treated 
with celastrol and MG132 (Walcott and Heikkila, 2010; Young and Heikkila, 2010). 
3.7 Analysis of HSP30 and HSP70 accumulation in A6 cells recovering from 
WA treatment 
In recovery experiments, cells were treated with 5 µM WA for 4 h and were then 
allowed to recover in fresh L-15 media for 6, 8 or 12 h. The relative levels of both HSP30 
and HSP70 protein were assessed by immunoblot analysis (Fig. 18a) and densitometry (Fig. 
18b). HSP30 and HSP70 accumulation increased in WA-treated cells allowed to recover for 
6 h and remained elevated until 12 h, compared to cells exposed to WA without a recovery 
period. Densitometric analysis revealed that exposure of cells to 5µM WA for 4 h followed 
by a 6 h recovery period, resulted in a 6.6-fold increase in HSP30 accumulation and a 4.4-
fold increase in HSP70 accumulation, compared to non-recovered, WA-treated cells.  
3.8 The effect of WA on the acquisition of thermotolerance in A6 cells 
In previous studies, it was established that pretreatment of A6 cells with a 33 °C heat 
shock or MG132 resulted in the accumulation of HSPs and an acquired state of 
thermotolerance (Manwell and Heikkila, 2007; Young and Heikkila, 2010). To assess 
whether WA can produce the same effect, A6 cells were pretreated with WA prior to a 
thermal challenge at 37 °C (Fig. 19). Cells treated with 2 µM WA for 6 h with a 12 h 






Figure 18. Effect of extended recovery on HSP30 and HSP70 accumulation in WA-
treated A6 cells. A) Cells were maintained at 22 °C and treated with DMSO (C), or with 5 
µM WA for 4 h followed by 0, 6, 8 or12 h recovery in WA-free L-15 media. Following 
recovery, cells were harvested and total protein was isolated. Immunoblot analysis was 
performed using anti-HSP30, anti-HSP70 and anti-actin polyclonal antibodies. B) Image J 
software was used to perform densitometric analysis of the signal intensity for HSP30 (grey) 
and HSP70 (outline) protein bands of the immunoblots as described in Materials and 
methods. The data are expressed as a percentage of the maximum band while the standard 
error is represented by vertical error bars. The level of significance of the differences 
between samples was calculated by one-way ANOVA with a Tukey’s post-test. Significant 
differences between control cells and those exposed to 5 µM WA are indicated as * (p<0.05). 









Figure 19. Cytoprotective effects of pretreating A6 cells with WA prior to a 37 °C 
thermal challenge. Cells were cultured on base-washed glass coverslips and maintained at 
22 °C (C), exposed to 2 µM WA for 6 h with an12h recovery at 22 °C in WA-free media  
followed by a 37 °C heat shock for 1 h with a 6 h recovery at 22 °C. In the last row, cells 
were pretreated with 100 µM KNK437 for 6 h before the WA treatment and subsequent 
thermal challenge. Actin and nuclei were stained directly with phalloidin conjugated to 
TRITC (red) and DAPI (blue), respectively. HSP30 was indirectly detected with an anti-
HSP30 antibody and a secondary antibody conjugated to Alexa-488 (green). The pink arrows 
indicate HSP30 associated foci. The 10 µM white scale bars are indicated at the bottom right 




therefore these conditions were employed in the present study. Shifting the incubation 
temperature from 22 °C directly to a 37 °C thermal challenge for 1 h resulted in the collapse 
of the actin cytoskeleton and distinct cell rounding. However, cells exposed to a WA 
pretreatment before the thermal challenge maintained their cytoskeletal organization and 
stress fibres. Similar results were obtained in cells pretreated with concurrent 2 µM WA and 
30 °C heat shock prior to a 37 °C thermal challenge in that all of the cells exhibited control 
like stress fibres and an intact cytoskeleton (Fig. 20). In contrast, cells heat shocked at 30 °C 
prior to a 37 °C thermal challenge had a disorganized actin cytoskeleton and slightly rounded 









Figure 20. Cytoprotective effects of pretreating A6 cells concurrently with WA and 
mild heat shock prior to a 37 °C thermal challenge. Cells were cultured on base-washed 
glass coverslips and maintained at 22 °C (C), exposed to 2 µM WA for 6 h at 30 °C followed 
by a 12 h recovery period in WA-free media at 22 °C with or without a  37 °C heat shock for 
1 h with a 6 h recovery at 22 °C. In the last row, cells were pretreated with 100 µM KNK437 
for 6 h before the combined treatment and subsequent thermal challenge. Actin and nuclei 
were stained directly with phalloidin conjugated to TRITC (red) and DAPI (blue), 
respectively.  HSP30 was indirectly detected with an anti-HSP30 antibody and a secondary 
antibody conjugated to Alexa-488 (green). The 10 µM white scale bars are indicated at the 
bottom right section of each panel. These data are representative of three separate 










Figure 21. Effects of pretreating A6 cells with mild heat shock prior to a 37 °C thermal 
challenge. Cells were cultured on base-washed glass coverslips and maintained at 22 °C (C), 
or 30 °C for 6 h followed by a 12 h recovery period at 22 °C with or without a  37 °C heat 
shock for 1 h with a 6 h recovery at 22 °C. Actin and nuclei were stained directly with 
phalloidin conjugated to TRITC (red) and DAPI (blue), respectively.  HSP30 was indirectly 
detected with an anti-HSP30 antibody and a secondary antibody conjugated to Alexa-488 
(green). The white arrows indicate ruffled edges of the actin cytoskeleton. The 10 µM white 
scale bars are indicated at the bottom right section of each panel. These data are 







The present study determined that WA inhibited proteasomal activity and induced 
hsp30 and hsp70 gene expression in Xenopus laevis A6 kidney epithelial cells. Initial studies 
demonstrated that exposure of A6 cells to 5 µM WA enhanced the relative levels of 
ubiquitinated protein. These results were comparable to the effects of the proteasomal 
inhibitor, MG132, documented previously in our laboratory (Young and Heikkila, 2010). 
Additionally, cells treated with 5 µM WA exhibited a 45% to 70% decrease in chymotrypsin-
like activity. Taken together the WA-induced increase in the accumulation of ubiquitinated 
protein and decreased chymotrypsin-like activity in A6 cells, is an indicator of proteasomal 
inhibition. Similarly, treatment of human prostate cancer (PC-3) cells with 5 to 20 µM WA 
for 4 h resulted in an increase in ubiquitinated protein in a dose dependent manner (Yang et 
al., 2007). Also, chymotrypsin-like activity of PC-3 cells was inhibited by 50% after 
treatment with 20 µM WA for 16 h. Yang et al. (2007) suggested that WA-induced 
proteasomal inhibition resulted from the direct interaction between WA and the β5 subunit, 
with chymotrypsin-like activity, of the 20S proteasome. In silico docking and nucleophilic 
attack studies were used to produce a computer model of the interaction and reaction between 
WA and the 26S proteasome (Yang et al., 2007). C1 and C24 of WA are in range for direct 
interaction with the N-terminal threonine, the catalytically active amino acid, of the β5 
subunit. This indicates that WA may interact directly interact with the 20S proteasome to 
inhibit its chymotrypsin-like activity. 
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In Xenopus laevis A6 cells, like other eukaryotic systems, the ubiquitin-proteasome 
system (UPS) is the primary degradation pathway for misfolded or damaged proteins (Lee 
and Goldberg, 1998; Malik et al., 2001). Previous studies have shown that inhibiting the 
activity of the proteasome leads to the accumulation of damaged or unfolded proteins within 
the cell which are targeted for degradation by the addition of polyubiquitin chains (Bush et 
al., 1997; Lee and Goldberg, 1998; Malik et al., 2001; Liao et al., 2006). Since misfolded 
proteins possess exposed hydrophobic amino acid residues, increased concentrations of these 
non-native proteins can result in aggregate formation, which is detrimental to cell function 
(Hartl 1996; Lee and Goldberg, 1998; Hartl and Hayer-Hartl, 2009). Under stress conditions, 
unfolded protein is thought to be a signal for the activation of hsp gene expression (Voellmy 
et al., 2004). 
As mentioned above, treatment of A6 cells with WA resulted in the accumulation of 
hsp30 and hsp70 mRNA as well as HSP30 and HSP70 protein. In these experiments, WA 
had no detectable effect on actin protein levels. Moreover, the accumulation of HSP30 and 
HSP70 increased with increasing time up to 24 h. These findings are in agreement with 
previous studies in our laboratory, which demonstrated that proteasomal inhibition by 
MG132 and celastrol induced hsp gene expression in A6 cells (Walcott and Heikkila, 2010; 
Young and Heikkila, 2010). In addition to proteasomal inhibition, WA-induced ROS 
generation may result in increased cellular unfolded protein (Malik et al., 2007).  This 
suggests that various avenues exist for WA-induced hsp gene expression. The effects of WA 
on hsp gene expression were only examined in one other system, human pancreatic cells, in 
which their treatment with 10 µM WA increased the protein level of HSP70 by 13.47-fold 
after 6 h (Yu et al., 2010).  
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In experiments employing various concentrations of WA, HSP70 was detected in 
cells treated with 2 µM whereas HSP30 was first detected in cells treated with 5 µM. 
Similarly, HSP70 was detected earlier than HSP30 in cells treated with 5 µM WA. This 
discrepancy may be due to variation in the synthesis or processing of HSP30 compared to 
HSP70 or the sensitivity of the antibodies used to detect the protein accumulation. Previous 
studies in our laboratory found a similar anomaly in A6 cells treated with heat shock, 
celastrol and MG132 (Young et al., 2009; Walcott and Heikkila, 2010; Young and Heikkila, 
2010). For example, experiments employing MG132 found that HSP70 was detected in A6 
cells treated with lower concentrations than was HSP30. Also, HSP70 was detected earlier 
than HSP30 in cells treated with 50 µM MG132 (Young and Heikkila, 2010). 
In time course experiments HSP30 and HSP70 accumulation increased significantly 
in cells exposed to 5 µM WA, from 8 to 24 h. Comparatively, in A6 cells exposed to 
continuous heat shock HSP30 and HSP70 accumulation was detected after 1 h and maximal 
levels were observed after 2 h (Darasch et al., 1988). Reasons for the variation amongst 
temporal patterns of HSP accumulation in A6 cells subjected to heat shock and WA are 
unknown. The delay in elevated HSP accumulation in A6 cells treated with WA may be due 
to the time required for WA to enter the cell and subsequently increase the unfolded protein 
levels required to initiate HSF1-HSE-binding activity. In support of this concept, a delayed 
accumulation of HSPs compared to heat shock was observed in A6 cells exposed to sodium 
arsenite, cadmium chloride, celastrol, MG132, or herbymicin A (Darasch et al., 1988; Ohan 
et al., 1998; Gauley and Heikkila, 2006; Woolfson and Heikkila, 2009; Walcott and Heikkila, 
2010; Young and Heikkila, 2010). For example, celastrol-treated A6 cells displayed 
detectable HSP70 and HSP30 accumulation after 2 and 6 h, respectively, with maximal HSP 
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accumulation occurring after 18 h (Walcott and Heikkila, 2010).  Also, in A6 cells exposed 
to MG132, HSP70 and HSP30 were detected after 4 and 8 h, respectively with maximal HSP 
levels occurring after 24 h (Young and Heikkila, 2010).  
The molecular and cellular mechanisms associated with the stress-inducible hsp gene 
expression during proteasomal inhibition are unclear. A simplified model of how WA 
interacts with the proteasome to induce hsp gene expression is shown in Figure 22. The 
proteasome degrades 80-90% of all proteins and inhibition of its activity results in a 
substantial increase in the concentration of total cellular protein (Lee and Goldberg, 1998). 
Excess proteins, particularly damaged or aged, are prone to misfolding, which may expose 
their hydrophobic amino acid residues and lead to aggregation. In Xenopus, the stress-
induced expression of hsp genes is mediated by HSF1-HSE-binding activity and the 
accumulation of unfolded protein by proteasomal inhibition may trigger HSF1 activiation 
(Morimoto and Santoro, 1998; Heikkila, 2003; Voellmy, 2004; Morimoto, 2008; Heikkila, 
2010). The involvement of HSE-HSF1-binding activity in WA-induced expression of hsp 
genes was determined using the HSF1 inhibitor, KNK437. Treatment of A6 cells with 
KNK437, prior to the addition of WA, inhibited the accumulation of both HSP30 and 
HSP70. This suggested that WA-induced hsp gene expression in Xenopus A6 cells was 
transcriptionally mediated, at least in part, via the activation of HSF1 DNA-binding. Similar 







Figure 22. Model of the effect of WA on proteasomal activity and hsp gene expression. 
WA inhibits proteasomal activity (1) which leads to a build up of ubiquitinated and denatured 
protein (2). HSPs are recruited away from inactive HSF1 monomers to bind unfolded and 
possibly ubiquitinated protein (3). HSF1 monomers are then free to trimerize (4). Active 
trimers translocate to the nucleus where they activating the synthesis of hsp genes (5). Newly 
synthesized HSPs bind to the excess unfolded and possibly ubiquitinated protein in the cell 




with KNK437, repressed heat shock-, chemical stress- and celastrol-induced hsp gene 
expression (Manwell and Heikkila, 2007; Voyer and Heikkila, 2008; Walcott and Heikkila, 
2010; Young and Heikkila, 2010). This study shows for the first time that WA-induced hsp30 
and hsp70 gene expression is controlled, at least in part, by HSF1-HSE binding activity. 
In A6 cells, concurrent treatment with both mild heat shock and WA induced elevated 
levels of HSP30 and HSP70 accumulation. In fact, the relative levels of HSP30 and HSP70 
accumulation induced by the concurrent stresses were greater than the sum of the levels 
found with each stress individually. Enhanced induction of hsp gene expression was 
previously reported in Xenopus A6 kidney epithelial cells treated simultaneous with 
relatively mild heat shock temperatures and herbimycin A, hydrogen peroxide, cadmium 
chloride, sodium arsenite or celastrol (Briant et al., 1997; Muller et al., 2004; Woolfson and 
Heikkila, 2009, Young et al., 2009; Walcott and Heikkila, 2010).The mechanism responsible 
for elevated levels of HSP30 and HSP70 in A6 cells induced by combined WA and mild heat 
shock is not clear. As mentioned previously, an increase in the relative levels of ubiquitinated 
protein destined for degradation resulted from WA-induced proteasomal inhibition. In 
addition, elevated temperatures can induce a generalized unfolding of intracellular proteins. 
Thus, it is possible that exposure of A6 cells to a combined mild heat shock and WA 
treatment elevated the total level of unfolding protein to a threshold point necessary for HSF1 
activation. Support for the existence of a threshold level for HSF1 activation has been 
demonstrated in several organisms including mouse T-lymphocytes and testis, Xenopus,, 
HeLa cells and intertidal mussels (Lee et al., 1995; Sarge, 1995; Ali et al., 1997; Buckley et 
al., 2001; Gothard et al., 2003). 
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Immunocytochemistry and LSCM were employed to examine the localization of 
HSP30 in A6 cells treated with WA. Cells exposed to 5 µM WA displayed HSP30 
accumulation primarily in the cytoplasm in a punctate pattern with a lesser amount in the 
nucleus. The granular or punctate pattern of HSP30 accumulation may be due to the stress-
induced formation of HSP30 multimeric structures that are required for sHSP function (Ohan 
et al., 1998; MacRae, 2000; Van Montfort et al., 2001).  Additionally, relatively large HSP30 
staining foci were detected in cells exposed to 5 µM WA for 18 h. Similar structures were 
reported in A6 cells exposed to cadmium chloride, sodium arsenite, celastrol or MG132 
(Voyer and Heikkila, 2008; Woolfson and Heikkila, 2009; Walcott and Heikkila, 2010; 
Young and Heikkila, 2010). Although the identity of these large structures is unknown, it has 
been suggested that they are inclusion bodies containing HSP30 bound to unfolded proteins 
and may be associated with the molecular chaperone function of HSP30 (Fernando and 
Heikkila, 2000; Heikkila, 2003; Heikkila, 2004; Young and Heikkila, 2010). In support of 
this possibility, previous studies have determined that treating cells with compounds that 
inhibit proteasome activity significantly increased the formation of cytosolic aggresomes, 
proteinaceous inclusion bodies that form as a general cellular response to aggregated proteins 
(Garcia-Mata et al., 1999). Previously, our laboratory determined that these HSP30 staining 
foci occurred in response to high concentrations of MG132 (Young and Heikkila, 2010). 
Lastly, the current study determined that treatment of A6 cells with WA for 8 h did not 
visibly disrupt the actin cytoskeleton, which has been used as an indicator of cellular viability 
and health (Wiegant et al., 1987; Ohtsuka et al., 1993). However, after extended WA 
treatment A6 cells showed some actin disorganization with the formation of numerous 
punctate areas of actin aggregation and peripheral ruffled edges. Enhanced accumulation of 
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HSP30 in A6 cells treated concurrently with WA and a mild heat shock, compared to the 
stresses individually, was verified by immunocytochemistry and LSCM. HSP30 accumulated 
primarily in the cytoplasm in a punctate pattern with some in the nucleus. It was also noted 
that the combined stress conditions caused membrane ruffling and HSP30 associated foci.  
WA-induced actin aggregation was previously reported in mammalian systems and 
may be due to the interaction of WA with the intermediate filament protein vimentin, and 
annexin II, which has basal F-actin cross-linking activity. In support of this possibility, 
Bargagna-Mohan et al. (2007) demonstrated that bovine aortic endothelial cells exposed to 3 
µM WA for 18 h showed the presence of numerous vimentin-positive staining particles in the 
cytoplasm, which strongly co-stained for actin. In addition, annexin II-transduced WI-38 
human fibroblasts displayed increased levels of F-actin aggregation after treatment with 4 
µM WA for 2 h (Borm et al., 2005). Several of these compact areas of actin co-localized with 
the HSP30 associated foci (Fig. 15). In previous studies, the actin cytoskeleton of sodium 
arsenite-treated A6 cells displayed some disorganization that co-localized with areas of 
HSP30 enrichment (Gallalchew and Heikkila, 2005).   
The mechanism responsible for WA-induced cell membrane ruffling is not well 
understood. In general ruffling is the formation of a motile cell surface that contains a 
meshwork of newly polymerized actin filaments under the plasma membrane and may 
indicate global instability of cellular adhesion (Borm et al., 2005). Previous studies have 
demonstrated that membrane ruffling was induced by extracellular influences such as growth 
factors and heat shock (Mellstrom et al., 1988; Chan et al., 1998; Svitkina and Borisy, 1999; 
Borisy and Svitkina, 2000; Cooper and Schafer, 2000; Hamilton and Heikkila, 2005). For 
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example, one of the earliest effects of platelet-derived growth factor on human fibroblasts in 
culture is an induction of membrane ruffling (Mellstrom et al., 1988). 
The present study also investigated the pattern of HSP accumulation in Xenopus A6 
cells recovering from WA treatment. Relative levels of HSP30 and HSP70 accumulation 
remained elevated for 6 to 12 h after the removal of WA. These findings were similar to 
results described in A6 cells recovering from celastrol, in which the relative levels of HSP30 
and HSP70 remained elevated for 18 to 24 h (Walcott and Heikkila, 2010). Additionally, a 
prolonged accumulation of HSPs was reported in Chinese hamster ovary cells recovering 
from proteasomal inhibition (Kovacs et al., 2006). The lingering accumulation of HSPs in A6 
cells recovering from WA may be due to continued hsp gene transcription or an increase in 
hsp mRNA or HSP stability, as suggested previously for sodium arsenite (Darasch et al., 
1988). Even so, it is likely that elevated levels of HSPs are beneficial to WA-treated cells 
since relatively high concentrations of ubiquitinated cellular proteins that accumulate within 
the cytosol may require an extended amount of time to re-establish protein homeostasis by 
degradation (Bush et al., 1997; Lee and Goldberg, 1998; Liao et al., 2006).  
The present study also determined that A6 cells acquired a state of thermotolerance 
when treated with WA, such that they were able to maintain their cytoskeletal organization 
after a subsequent thermal challenge at 37 °C, which is normally cytotoxic (Fig. 20). 
Pretreatment with KNK437 inhibited HSP30 accumulation and failed to result in WA-
induced thermotolerance as indicated by the disruption of the actin cytoskeleton. This 
signifies that HSPs, including HSP30, are required for the acquisition of thermotolerance in 
A6 cells treated with WA. A cytoprotective effect was also demonstrated in cells treated with 
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concurrent WA and mild heat shock (Fig. 21) but not in mild heat shock alone (Fig. 22), prior 
to a 37 °C thermal challenge.   
In summary, this study has shown for the first time that the natural product, WA, 
induced hsp30 gene expression. In addition, this study has demonstrated for the first time, in 
an amphibian system, that WA induced hsp70 gene expression, increased the accumulation 
of ubiquitinated proteins, inhibited chymotrypsin-like activity and partially disrupted the 
actin cytoskeleton. Understanding the effect that WA has on Xenopus hsp gene expression is 
of importance given the potential therapeutic role for HSPs in various human diseases. 
Proteasome dysfunction and hsp gene expression have been implicated in numerous 
neuropathologies, including Alzheimer’s disease (Morimoto, 2008).  A consistent feature of 
Alzheimer’s disease is the presence of ubiquitinated tau-positive inclusion bodies containing 
HSPs in oligodendrocytes (Goldbaum and Landsberg, 2004). This suggests that the 
proteasome and HSPs have an essential role in maintaining tau protein homeostasis and 
malfunction of these processes could lead to disease states.  
This study leaves some unanswered questions about the effects of WA on hsp gene 
expression. Therefore, further analysis on the relationship between WA-induced proteasome 
inhibition and the accumulation of HSPs is required. Future studies should examine the effect 
of WA on other Xenopus hsp genes such as hsp27, BiP, hsp47, hsp90 and hsp110.  As well, 
further experiments are needed to determine if the multiple bands detected with anti-HSP30 
are the products of different hsp30 family members or post-translationally modified proteins. 
Mammalian studies have suggested that proteasome inhibition may have an impact on 
molecular chaperones in the endoplasmic reticulum and HSP90 (Bush et al., 1997; Banerji, 
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2009). Given the advantages of the Xenopus embryonic system including microinjections and 
transgenic methodology, future experiments should examine the effects of WA on hsp gene 
expression during early development. Also, the effect of proteasome inhibition on hsp gene 
expression during animal development has not been investigated. Additionally, experimental 
evidence is needed to explain the large cytoplasmic foci containing HSP30 observed in A6 
cells exposed to WA. Formation of aggresomes in mammalian cells was paralleled by the 
redistribution of the intermediate filament protein vimentin as well as by the recruitment of 
the proteasome, and the hsp70 systems of chaperones (Garcia-Mata et al., 1999). Therefore, a 
test for co-localization of vimentin or HSP30, utilizing immunocytochemistry and LSCM, 
would help to determine if these foci are stress granules or inclusion bodies. Previous studies 
have also shown that WA can induce apoptosis through inhibition of the NF-kβ signaling 
pathway (Mohan et al., 2004j; Malik et al., 2007; Idris et al., 2009). Therefore, the potential 
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